Nutrient requirements for preterm infant formulas

Journal of Nutrition

Volumn 132, Issue 6 SUPPL. 2, 2002, Pages

  Klein, Catherine J ^a  

^a Life Sciences Research Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CASEIN; LACTOSE; TAURINE;

ARTIFICIAL MILK; CALCULATION; CHILD CARE; CHILD DEVELOPMENT; CHILD GROWTH; FOOD AND DRUG ADMINISTRATION; FOOD INTAKE; FOOD QUALITY; GROWTH RATE; HUMAN; INFANT; INFANT FEEDING; INFANT NUTRITION; MEDICAL SOCIETY; NUTRIENT; NUTRITIONAL REQUIREMENT; ORGANOGENESIS; PRACTICE GUIDELINE; PREMATURITY; REVIEW; WHEY;

CHILD DEVELOPMENT; EMBRYONIC AND FETAL DEVELOPMENT; HUMANS; INFANT; INFANT FOOD; INFANT, NEWBORN; INFANT, PREMATURE; NUTRITIONAL REQUIREMENTS;

EID: 0036269911     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (1460)

1. Effects of fluoride supplementation from birth on human deciduous and permanent teeth
2. Effects of fluoride supplementation from birth on dental caries and fluorosis in teenaged children
3. Dual tracer stable isotopic assessment of calcium absorption and endogenous fecal excretion in low birth weight infants
4. Hypercalciuria in premature infants receiving high mineral-containing diets
5. Molybdenum-is it an essential trace metal?
6. Amino acid intolerance during prolonged total parenteral nutrition reversed by molybdate therapy
7. Reference ranges for newer thyroid function tests in premature infants
8. Neonatal trace element metabolism
9. Trace elements of the micropremie
10. Symptomatic zinc deficiency in a breast-fed preterm infant
11. Sodium homeostasis in term and preterm neonates. I. Renal aspects
12. Sodium homeostasis in term and preterm neonates. II. Gastrointestinal aspects
13. Sodium homeostasis in term and preterm neonates. III. Effect of salt supplementation
14. Manganese levels in serum of healthy Venezuelan infants living in Merida
15. Mineral and trace-metal balances in children receiving normal and synthetic diets
16. A United States national reference for fetal growth
17. Measurement of bone mineral density by dual energy X-ray absorptiometry in preterm infants fed human milk or formula
18. Nonprotein nitrogen compounds in bovine milk
19. Plasma zinc concentration and catch up growth in preterm infants
20. Taurine promotes the differentiation of a vertebrate retinal cell type in vitro
21. Fetal growth in different racial groups
22. Vitamin K compounds and the water-soluble analogues. Use in therapy and prophylaxis in pediatrics
23. The transfer of drugs and other chemicals into human milk
24. Nomenclature for duration of gestation, birth weight, and intra-uterine growth
25. Hospital discharge of the high-risk neonate-proposed guidelines
26. Commentary on breast-feeding and infant formulas, including proposed standards for formulas
27. Nutritional needs of low-birth-weight infants
28. Recommended ranges of nutrients in formulas
29. Fluoride supplementation
30. Nutritional needs of preterm infants
31. Nutritional needs of preterm infants
32. Selenium in premature infants
33. Inositol and glucocorticoid in the development of lung stability in male and female rabbit fetuses
34. The influence of dietary inositol on glyceride composition and synthesis in livers of rats fed different fats
35. Energy and macronutrient content of human milk during early lactation from mothers giving birth prematurely and at term
36. Chapter 7. Chromium
37. Chromium, glucose intolerance and diabetes
38. Role of chromium in glucose intolerance, diabetes, total parenteral nutrition, and body composition
39. A controlled trial of glucose versus glucose and amino acids in premature infants
40. Vitamin C: Report of trials with massive doses
41. Dietary intake of total and glycosylated vitamin B-6 and the vitamin B-6 nutritional status of unsupplemented lactating women and their infants
42. Development of the human coagulation system in the healthy premature infant
43. Disorders of iron metabolism
44. Early postnatal dexamethasone therapy for the prevention of chronic lung disease
45. Development and distribution of lysosomal enzymes and disaccharidases in human fetal intestine
46. Sodium excretion in relation to sodium intake and aldosterone excretion in newborn pre-term and full-term infants
47. Salt content in human breast milk during the three first weeks after delivery
48. Sodium, chloride, and potassium needs in very low birthweight infants
49. Trace element content in human milk during lactation of preterm newborns
50. Plasma ascorbic acid levels in premature infants
51. Zinc deficiency in two infants during total parenteral alimentation for diarrhea
52. Sodium, chloride, and potassium
53. Birth weight percentiles by gestational age in Canada
54. Iodine content of infant formulas and iodine intake of premature babies: High risk of iodine deficiency
55. Short-chain fatty acids induce reversible injury of porcine colon
56. Calcium and phosphorus
57. Morbidity and mortality among low birth weight infants exposed to an intravenous vitamin E product, E-Ferol
58. A developmental safety study in rats using DHA- and ARA-rich single-cell oils
59. A combined subchronic (90-day) toxicity and neurotoxicity study of a single-cell source of docosahexaenoic acid triglyceride (DHASCO oil)
60. In vitro genotoxicity testing of ARASCO and DHASCO oils
61. The dietary chloride deficiency syndrome occurring in a breast-fed infant
62. Major minerals and ionic constituents of human and bovine milks
63. Absorption and retention of macro and trace minerals in premature infants fed human milk
64. Effects of gestational stage at delivery on human milk components
65. Human milk feeding in premature infants: Protein, fat, and carbohydrate balances in the first two weeks of life
66. Human milk: Difference in nitrogen concentration in milk from mothers of term and premature infants
67. Amino acid metabolism and requirements of the premature infant: Is human milk the "gold standard"?
68. Nonprotein nitrogen fractions of human milk
69. Macromineral balances in premature infants fed their own mother's milk or formula
70. Macro-mineral content of milk obtained during early lactation from mothers of premature infants
71. Calcium and phosphorus fortification of preterm formulas: Drug-mineral and mineral-mineral interactions
72. Zinc needs of premature infants to one year of age
73. Abnormal zinc content in human milk. Risk for development of nutritional zinc deficiency in infants
74. Growth and development in term infants fed long-chain polyunsaturated fatty acids: A double-masked, randomized, parallel, prospective, multivariate study
75. Inositol and pyrroloquinoline quinone
76. Intestinal glycosidase activities in the human embryo, fetus, and newborn
77. Transient tyrosinemia of the newborn: Dietary and clinical aspects
78. Fetal growth. Liveborn birth weights for gestational age of white middle class infants
79. Diet and growth in the premature infant. The effect of different dietary intakes of ash-electrolyte and protein on weight gain and linear growth
80. Medium-chain triglycerides: An update
81. Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity
82. Vitamin concentrations in very low birth weight infants given vitamins intravenously in a lipid emulsion: Measurement of vitamins A, D, and E and riboflavin
83. Daily dose of fluoride and dental fluorosis
84. Tissue zinc levels and zinc excretion during experimental zinc depletion in young men
85. Folate metabolism and requirements
86. Lessons from the E-Ferol tragedy
87. Transient hyperammonemia of the preterm infant
88. Homeostatic control of manganese excretion in the neonatal rat
89. Diet and faecal flora in the newborn: Nucleotides
90. Urinary riboflavin excretion and erythrocyte glutathione reductase activity in preschool children suffering from upper respiratory infections and measles
91. Reduced erythrocyte superoxide dismutase activity in low birth weight infants given iron supplements
92. "Risk periods" associated with the development of dental fluorosis in maxillary permanent central incisors: A meta-analysis
93. Dietary factors in neonatal calcium homoeostasis
94. Breath hydrogen excretion in normal newborn infants in response to usual feeding patterns: Evidence for "functional lactase insufficiency" beyond the first month of life
95. Evidence for the safety of ascorbic acid administration to the premature infant
96. Bioavailability of riboflavin
97. Breast milk as a source of vitamins, essential minerals and trace elements
98. Hyperammonemia
99. Asymptomatic hyperammonemia in low birthweight infants
100. Arginine-responsive asymptomatic hyperammonemia in the premature infant
101. Birth weight, gestational age, and pregnancy outcome, with special reference to high birth weight-low gestational age infant
102. Fluoride uptake in hard tissues of fetal guinea pigs in response to various dose regimens
103. Hepatic concentrations of zinc, copper and manganese in infants with extra-hepatic biliary atresia
104. Tissue selenium accretion in premature and full-term human infants and children
105. Early effect of myo-inositol deficiency on fatty acid synthetic enzymes of rat liver
106. Statistical approaches to establish mineral element recommendations Deliberations and evaluations of approaches, endpoints and paradigms for determining zinc dietary recommendations
107. La nutrition iodée chez l'enfant
108. Towards the physiological function of uric acid
109. Diet and body composition of preterm infants
110. Influence of energy and protein intake on energy utilization and body composition of small premature infants
111. Feeding selenium supplemented formula improves selenium status in infants with bronchopulmonary dysplasia
112. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder
113. Membrane fatty acids associated with the electrical response in visual excitation
114. Measuring gestational age: An uncertain proposition
115. Iron overload, free radical damage, and rhesus haemolytic disease
116. Curd and whey proteins in the nutrition of low birthweight babies
117. Antioxidant activity of vitamin C in iron-overloaded human plasma
118. Fatty acid composition of lipid classes in maternal and cord plasma at birth
119. Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia
120. Clinical conditions altering copper metabolism in humans
121. 6 and infantile convulsions: A first approximation of requirements of pyridoxine in infants
122. Formulas for premature infants: Fate of the calcium and phosphorus
123. Effect of protein/energy ratio on growth and behavior of premature infants: Preliminary findings
124. Determination of mineral contents in different kinds of milk and estimation of dietary intake in infants
125. Report of the IDECG Working Group on lower and upper limits of carbohydrate and fat intake
126. Measurement of "true" glucose production rates in infancy and childhood with 6,6-dideuteroglucose
127. Assessment of whole-body protein-nitrogen kinetics in the human infant
128. Dietary essential fatty acid supply and visual acuity development
129. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants
130. Increased bone mineral content of preterm infants fed with a nutrient enriched formula after discharge from hospital
131. Comparison of the phospholipid composition of breast milk from mothers of term and preterm infants during lactation
132. Comparison of the lipid composition of breast milk from mothers of term and preterm infants
133. Alpha-linolenic acid deficiency in patients on long-term gastric-tube feeding: Estimation of linolenic acid and long-chain unsaturated n-3 fatty acid requirement in man
134. The effects of iron deficiency on the respiratory function and cytochrome content of rat heart mitochondria
135. Choline biosynthesis by a preparation enriched in synaptosomes from rat brain
136. Developmental changes in the activity of phosphatidylethanolamine N-methyltransferases in rat brain
137. Effect of increasing dietary threonine intakes on amino acid metabolism of the central nervous system and peripheral tissues in growing rats
138. Relationship between urea and ammonium excretion in the urine of very-low-birth-weight infants appropriate for gestational age
139. Calcium and phosphorus homeostasis in very-low-birth-weight infants appropriate for gestational age fed human milk
140. Metabolic consequences of high protein intake in premature infants appropriate for gestational age
141. Evidence for functional immaturity of the ornithine-urea cycle in very-low-birth-weight infants
142. Influence of postnatal age on nitrogen metabolism in very low birth weight infants appropriate for gestational age
143. Development of urea-synthesizing capacity in preterm infants during the first weeks of life
144. Antioxidative vitamins in prematurely and maturely born infants
145. Vitamin K in preterm breastmilk with maternal supplementation
146. Measurement of urinary iodine excretion to reveal iodine excess in neonatal transient hypothyroidism
147. Acquired dermatitis due to zinc deficiency in a premature infant
148. Effects of parenteral L-carnitine supplementation on fat metabolism and nutrition in premature neonates
149. Iron nutritional status is improved in Brazilian preterm infants fed food cooked in iron pots
150. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids
151. 6 in infancy: Requirements and current feeding practices
152. Carnitine
153. Carnitine function
154. Carnitine in neonatal nutrition
155. Amorphous calcium phosphate: The contention of bone
156. Preclinical evaluation of single-cell oils that are highly enriched with arachidonic acid and docosahexaenoic acid
157. Zinc-induced copper deficiency in an infant
158. Molybdenum content of term and preterm human milk during the first 2 months of lactation
159. Chromium status of full-term and preterm newborns
160. Vasculopathic hepatotoxicity associated with E-Ferol syndrome in low-birth-weight infants
161. Digestion of human milk oligosaccharides by healthy infants evaluated by the lactulose hydrogen breath test
162. Human milk oligosaccharides: 130 Reasons to breast-feed
163. Research uses of the NBAS
164. Selenium in the nutrition of infants: Influence of the maternal selenium status
165. Energy
166. Carnitine-metabolism and functions
167. A standard of fetal growth for the United States of America
168. Myoinositol in small preterm infants: Relationship between intake and serum concentration
169. Intestinal calcium absorption in rats is stimulated by dietary lactulose and other resistant sugars
170. Net calcium absorption in premature infants: Results of 103 metabolic balance studies
171. Energy expenditure in the fetus and neonate: Sources of variability
172. Nutritional requirements of low and very low birthweight infants
173. Energy retention, energy expenditure, and growth in healthy immature infants
174. Human milk and preterm formula compared for effects on growth and metabolism
175. Energy balance, nitrogen balance, and growth in preterm infants fed expressed breast milk, a premature infant formula, and two low-solute adapted formulae
176. Postnatal growth curve of the infant with extremely low birth weight who was fed enterally
177. Forms of human milk folacin and variation patterns
178. Chromium deficiency after long-term total parenteral nutrition
179. Duodenal bile acid conjugation patterns and dietary sulphur amino acids in the newborn
180. Treatment of urea cycle disorders
181. Urea cycle enzymes
182. Highly elevated content of free myo-inositol in the cerebrospinal fluid of neonates
183. The response of pre-term low-birth-weight newborn infants to supplements of pteroylmonoglutamic acid and pteroylpolyglutamate
184. Response of low birthweight infant to treatment with folic acid
185. Assessment of copper status in preterm infants: Limited value of assays of erythrocyte copper concentration and superoxide dismutase activity
186. Evaluation of single-cell sources of docosahexaenoic acid and arachidonic acid: 3-Month rat oral safety study with an in utero phase
187. A new deficiency disease produced by the rigid exclusion of fat from the diet
188. Myo-inositol metabolism in the neonatal and developing rat fed a myo-inositol-free diet
189. Clostridial pathogenicity in experimental necrotising enterocolitis in gnotobiotic quails and protective role of bifidobacteria
190. Longitudinal changes in milk composition of mothers delivering preterm and term infants
191. Energy expenditure and deposition of breast-fed and formula-fed infants during early infancy
192. Patterns in electrolyte and nitrogen balance in the newborn premature infant
193. Magnesium therapy in premature neonates with apnea neonatorum
194. Magnesium in perinatal care and infant health
195. Rickets of prematurity: Controversies in causation and prevention
196. Chromium picolinate supplementation and resistive training by older men: Effects on iron-status and hematologic indexes
197. Evaluation of carnitine nutritional status in full-term newborn infants
198. Nutrient needs and feeding of premature infants
199. Vitamin C for prophylaxis of tyrosinemia in the newborn
200. A methodology for biokinetic studies using stable isotopes: Results of repeated molybdenum investigations on a healthy volunteer
201. Growth and phosphorus metabolism in premature infants fed human milk, fortified human milk, or special premature formula: Use of serum procollagen as a marker of growth
202. Trans Fatty acids: Infant and fetal development
203. Long-term feeding of formulas high in linolenic acid and marine oil to very low birth weight infants: Phospholipid fatty acids
204. First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula
205. Lower incidence of necrotizing enterocolitis in infants fed a preterm formula with egg phospholipids
206. Plasma retinol and retinol binding protein concentrations in premature infants fed preterm formual past hospital discharge
207. Docosahexaenoic acid status of preterm infants at birth and following feeding with human milk or formula
208. A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until two months
209. Arachidonic acid status correlates with first year growth in preterm infants
210. Growth and development of premature infants in relation to 3 and 6 fatty acid status
211. Long-chain fatty acids and early visual and cognitive development of preterm infants
212. Visualacuity development in healthy preterm infants: Effect of marine-oil supplementation
213. Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia
214. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants
215. Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants
216. The very low birth weight premature infant is capable of synthesizing arachidonic and docosahexaenoic acids from linoleic and linolenic acids
217. Upper limits of nutrients in infant formulas: Polyunsaturated fatty acids and trans fatty acids
218. Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: Possible role of nucleoside kinase(s)
219. The relationship of choline and carnitine in the choline deficient rat
220. Chromium (3) in hypoglycemia and in impaired glucose utilization in kwashiorkor
221. Dietary nucleotide effects upon immune function in infants
222. Postnatal inositol levels in preterm infants
223. Selenium in human tissues from New Zealand
224. Trace elements in tissues from New Zealanders: A compilation of published data
225. Trace minerals
226. Studies in human lactation: Zinc, copper, manganese and chromium in human milk in the first month of lactation
227. Studies in human lactation: Secretion of zinc, copper, and manganese in human milk
228. Copper, manganese, zinc, nickel, cadmium and lead in human foetal tissues
229. Trace elements
230. Growth patterns of low birth weight preterm infants: A longitudinal analysis of a large, varied sample
231. Copper deficiency impairs growth of infants recovering from malnutrition
232. Intakes and excretions of iron, copper, and zinc in the neonatal period
233. Plasma carnitine and breast milk carnitine intake in premature infants
234. Performance of dual-energy x-ray absorptiometry in evaluating bone, lean body mass, and fat in pediatric subjects
235. Growth and bone mineral status of discharged very low birth weight infants fed different formulas or human milk
236. Effects of human milk or formula feeding on the growth, behavior, and protein status of preterm infants discharged from the newborn intensive care unit
237. Effects of increased calcium and phosphorous formulas and human milk on bone mineralization in preterm infants
238. Calcium and phosphorus requirements in bone mineralization of preterm infants
239. Choline and carnitine
240. Postnatal growth of infants of < 1.3 kg birth weight: Effects of metabolic acidosis, of caloric intake, and of calcium, sodium, and phosphate supplementation
241. Liver cell proliferation and incidence of hepatocellular carcinomas in rats fed consecutively a choline-devoid and a choline-supplemented diet
242. Immunoglobulin and protein levels in breast milk produced by mothers of preterm infants
243. Manganese-induced behavioral dysfunction and its neurochemical mechanism in growing mice
244. Choline may be an essential nutrient in malnourished patients with cirrhosis
245. Total body bone mineral content in small-for-gestational-age, appropriate-for-gestational-age, large-for-gestational-age term infants and appropriate-for-gestational-age preterm infants
246. Effect of chelating agents on chromium absorption in rats
247. An updated view of the value of taurine in infant nutrition
248. The role of taurine in infant nutrition
249. Developmental renal physiology of the low birth weight pre-term newborn
250. The influence of gestational age, size for dates, and prenatal steroids on cord transferrin levels in newborn infants
251. Positron emission tomography scanning: Applications in newborns
252. The lungs and vitamin A
253. Extrauterine fatty acid accretion in infant brain: Implications for fatty acid requirements
254. Intrauterine fatty acid accretion rates in human brain: Implications for fatty acid requirements
255. Assessment of the efficacious dose of arachidonic and docosahexaenoic acids in preterm infant formulas: Fatty acid composition of erythrocyte membrane lipids
256. Determination of the optimal ratio of linoleic acid to α-linolenic acid in infant formulas
257. Polyunsaturated fatty acid regulation of hepatic gene transcription
258. A new mechanism for induced vitamin D deficiency in calcium deprivation
259. The metabolism of myo-inositol by the human kidney
260. A critical review of minimal vitamin B-6 requirements for growth in various species with a proposed method of calculation
261. Effects of lactose on intestinal calcium absorption in normal and lactase-deficient subjects
262. Overnutrition in prenatal and neonatal life: A problem?
263. Detection of a milk factor that facilitates folate uptake by intestinal cells
264. Individual differences in infant cognition: Methods, measures, and models
265. Sonographic estimation of fetal weight based on a model of fetal volume
266. Vitamin K
267. Commission Directive 96/4/EC of 16 February 1996 on infant formulae and follow-on formulae
268. Feeding preterm infants after hospital discharge: Effect of dietary manipulation on nutrient intake and growth
269. Nutrient retention in preterm infants fed standard infant formulas
270. Nutrient balance studies in the preterm infant: Crossover and parallel studies as methods of experimental design
271. Blood transfusion and chronic lung disease in preterm infants
272. Changes in carbohydrate composition in human milk over 4 months of lactation
273. Oligosaccharides in human milk during different phases of lactation
274. Clinical manifestations of nutritional copper deficiency in infants and children
275. Copper deficiency complicating severe chronic intestinal malabsorption
276. Carnitine depletion in the choline-deficient state
277. Sodium restriction versus daily maintenance replacement in very low birth weight premature neonates: A randomized, blind therapeutic trial
278. Effect of dietary arginine level on urinary orotate and citrate excretion in growing kittens
279. Persistent glucose production during glucose infusion in the neonate
280. The effect of hydrogenated fat in the diet of nursing mothers on lipid composition and prostaglandin content of human milk
281. Early hospital discharge of preterm very low birth weight infants
282. Graphite-furnace atomic absorption spectrometric determination and survey of total aluminum, copper, manganese, molybdenum, and tin in infant formulas and evaporated milks
283. Iron, vitamin E, and folate in the preterm infant
284. Biochemical basis for the manifestations of iron deficiency
285. 12
286. A grid for recording the weight of premature infants
287. Randomised clinical trial of parenteral selenium supplementation in preterm infants
288. Selenium status of preterm infants: The effect of postnatal age and method of feeding
289. Copper deficiency in humans
290. The influence of diet on the ascorbic acid requirement of premature infants
291. Threonine kinetics in pretrm infants fed their mothers' milk or formula with various ratios of whey to casein
292. The relationship of selenium status to respiratory outcome in the very low birth weight infant
293. The effect of selenium supplementation on outcome in very low birth weight infants: A randomized controlled trial
294. Comparative study on breast milk of mothers delivering preterm and term infants-protein, fat and lactose
295. The effect of iron supplements and blood transfusion on iron absorption by low birthweight infants fed pasteurized human breast milk
296. The absorption and retention of magnesium, zinc, and copper by low birth weight infants fed pasteurized human breast milk
297. Calcium metabolism in newborn infants: The interrelationship of parathyroid function and calcium, magnesium, and phosphorus metabolism in normal, "sick," and hypocalcemic newborns
298. Differing birth weight among infants of U.S.-born blacks. African-born blacks, and U.S.-born whites
299. Feeding studies in low-birth-weight infants. I. Relationships of dietary protein, fat, and electrolyte to rates of weight gain, clinical courses, and serum chemical concentrations
300. Manganese absorption from human milk, cow's milk, and infant formulas in humans
301. Manganese retention in man: A method for estimating manganese absorption in man
302. The effect of individual dietary components on manganese absorption in humans
303. Identification of transferrin as the major plasma carrier protein for manganese introduced orally or intravenously or after in vitro addition in the rat
304. Adequacy of expressed breast milk for early growth of preterm infants
305. Interactions among dietary manganese, heme iron, and nonheme iron in women
306. Varying levels of manganese and iron affect absorption and gut endogenous losses of manganese by rats
307. Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis
308. Effects of over-the-counter drugs on chromium retention and urinary excretion in rats
309. Clinical chemistry of folic acid
310. Electrolyte abnormalities in very low birthweight infants
311. Intraventricular hemorrhage in premature infants: Reappraisal and new hypothesis
312. Renal solute load in preterm infants
313. Skinfold thickness and adiposity index in premature infants
314. Fetal weight gain in a serially scanned high-risk population
315. Further studies of the minimal threshold of chronic endemic dental fluorosis
316. Growth, fatty acid composition of plasma lipid classes, and plasma retinoi and α-tocopherol concentrations in full-term infants fed formula enriched with ω-6 and ω-3 long-chain polyunsaturated fatty acids
317. Daily chromium intake by infants in Belgium
318. Physiopathology of iodine nutrition during pregnancy, lactation, and early postnatal life
319. Neonatal thyroid function in iodine deficiency
320. Evidence of a high requirement of iodine in preterm infants
321. 13C content
322. The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants
323. Glucose carbon recycling and oxidation in human newborns
324. Proteolysis and phenylalanine hydroxylation in response to parenteral nutrition in extremely premature and normal newborns
325. The effect of molybdenum levels in sorghum (Sorghum vulgare Pers.) on uric acid and copper excretion in man
326. Longitudinal studies of fetal growth using volume parameters determined with ultrasound
327. Milk and nutrient intake of breast-fed infants from 1 to 6 months: Relation to growth and fatness
328. Docosahexaenoic acid plus arachidonic acid enhance preterm infant growth
329. Total and free ionic fluoride in human and cow's milk as determined by gas-liquid chromatography and the fluoride electrode
330. Alterations in expression and methylation of specific genes in livers of rats fed a cancer promoting methyldeficient diet
331. The later growth of the brain and its vulnerability
332. Clinical applications of preferential looking measures of visual acuity
333. Visual acuity in human infants: A review and comparison of behavioral and electrophysiological studies
334. Effects of deficiency in manganese upon plasma levels of clotting proteins and cholesterol in man
335. Effect of taurine on calcium kinetics of guinea-pig heart
336. Neurotoxicity of manganese chloride in neonatal and adult CD rats following subchronic (21-day) high-dose oral exposure
337. Longitudinal manganese and copper balances in young infants and preterm infants fed on breast-milk and adapted cow's milk formulas
338. Manganese balances in term infants
339. Effects of amino acids on the absorption of trivalent chromium and its retention by regions of the rat small intestine
340. The effect of varying protein quality and energy intake on the nitrogen metabolism of parenterally fed very low birthweight (<1600 g) infants
341. A perinatal growth chart for international reference
342. Transport mechanisms for long-chain polyunsaturated fatty acids in the human placenta
343. Pathogenesis and treatement of neuroleptic malignant syndrome
344. 12
345. Iron requirements of preterm infants
346. Determination with stable isotopes of the dietary bioavailability of zinc in premature infants
347. 46Ca extrinsic tag
348. 58Fe
349. Zinc and copper nutritional studies in very low birth weight infants:
350. 74Se
351. Longitudinal growth of hospitalized very low birth weight infants
352. 12 requirements in premature infants
353. Plasma and red cell folate values and folate requirements in formula-fed premature infants
354. Plasma and red blood cell folate in breastfed infants
355. No evidence of transfer of fluoride from plasma to breast milk
356. Fluoride balance studies on infants in a 1-ppm-water-fluoride area
357. Absorption and retention of dietary and supplemental fluoride by infants
358. The utilization of exogenous taurine for the conjugation of xenobiotic acids in the ferret
359. Sodium balance in very low-birth-weight infants
360. Renal handling of beta-2-microglobulin in the human neonate
361. Urinary potassium excretion in the critically ill neonate
362. Maternal sodium intake does not affect postprandial sodium concentrations in human milk
363. Wide variations of fluoride supply to infants and their effect
364. Variability of human milk neutral oligosaccharides in a diverse population
365. Effect of maternal fluorine intake on breast milk fluorine content
366. Guidelines on infant nutrition. I. Recommendations for the composition of an adapted formula
367. Comment on the content and composition of lipids in infant formulas
368. Nutrition and feeding of preterm infants
369. Effect of high-dose vitamin D supplementation on radiographically detectable bone disease of very low birth weight infants
370. Bleomycin-detectable iron in the plasma of premature and full-term neonates
371. Diet and bone mineral content at term in premature infants
372. Infant recognition memory as a measure of intelligence
373. Toxicity and blood ammonia rise resulting from intravenous amino acid administration in man: The protective effect of L-arginine
374. Nutrient accretion in preterm infants fed formula with different protein: Energy ratios
375. Infant cerebral cortex phospholipid fatty-acid composition and diet
376. Enamel defects in the primary dentition of children born weighing less than 2000 g
377. Dental tissue effects of fluoride
378. The nature and mechanisms of dental fluorosis in man
379. Manganese toxicity in children receiving long-term parenteral nutrition
380. Brain iron and behavior of rats are not normalized by treatment of iron deficiency anemia during early development
381. 1 arrest induced in NRK cells by picolinic acid
382. Routine administration of vitamin K to newborns
383. Neonatal factors predicting childhood height in preterm infants: Evidence for a persisting effect of early metabolic bone disease?
384. Hypernatremic (hypertonic) dehydration in infants
385. Babies need sodium in moderation
386. Methionine metabolism in mammals. The methionine-sparing effect of cystine
387. Thyroid function in premature infants. The hypothyroxinemia of prematurity
388. Hypothyroxinemia in premature infants: Is thyroxine treatment necessary?
389. Comparative effects of iron deficiency induced by bleeding and a low-iron diet on the intestinal absorptive interactions of iron, cobalt, manganese, zinc, lead and cadmium
390. Body composition of the male reference infant during the first year of life
391. Fat
392. Protein
393. Vitamin C
394. B vitamins and choline
395. Calcium, phosphorus, magnesium, and sulfur
396. Size and Growth
397. Vitamin K
398. Requirements for protein and essential amino acids in early infancy: Studies with a soy-isolate formula
399. Water and renal solute load
400. Renal solute load and potential renal solute load in infancy
401. Requirement for sulfur-containing amino acids in infancy
402. Human milk and the small premature infant
403. Nutrient requirements for infant formulas
404. Current good manufacturing practice, quality control procedures, quality factors, notification requirements, and records and reports, for the production of infant formula
405. A note on the mathematics of "catch-up" growth
406. Calcium accumulation by the human fetus
407. Nutritional adequacy of human breast milk for prematurely born infants
408. Comparison of the B vitamin composition of milk from mothers of preterm and term babies
409. Influence of feeding artificial-formula milks containing docosahexaenoic and arachidonic acids on the postnatal long-chain polyunsaturated fatty acid status of healthy preterm infants
410. Growth and development in preterm infants during the first 18 months
411. Early supply of fluoride and enamel fluorosis
412. Dietary calcium and fluoride interactions in swine: In utero and neonatal effects
413. Mediation of the trophic effects of short-chain fatty acids on the rat jejunum and colon
414. Distribution of trace elements and minerals in human and cow's milk
415. Iron, copper, zinc, calcium, and magnesium in human milk fat
416. Importance of zinc in the central nervous system: The zinc-containing neuron
417. Metabolic balance of manganese in young men consuming diets containing five levels of dietary manganese
418. Deliberations and evaluations of the approaches, endpoints and paradigms for manganese and molybdenum dietary recommendations
419. Indigent Negro and Caucasian birth weight-gestational age tables
420. Ascorbate is an outstanding antioxidant in human blood plasma
421. A modified cows' milk formula suitable for low birthweight infants
422. Chromium deficiency during total parenteral nutrition
423. Manganese balance and clinical observations in young men fed a manganese-deficient diet
424. Relationship between serum inositol concentration and development of retinopathy of prematurity: A prospective study
425. 12 status of low-birth-weight infants receiving enteral nutrition
426. Elemental composition of human milk from mothers of premature and full-term infants during the first 3 months of lactation
427. 12 status of infants with low birth weights receiving enteral nutrition
428. Selenium status of very low birth weight infants
429. Zinc supplementation in very-low-birthweight infants
430. Serum zinc, copper, and selenium concentrations in preterm infants receiving enteral nutrition or parenteral nutrition supplemented with zinc and copper
431. Molybdenum requirements in low-birth-weight infants receiving parenteral and enteral nutrition
432. Zinc, copper, manganese, and iron balance of parenterally fed very low birth weight preterm infants receiving a trace element supplement
433. Elevated intakes of zinc in infant formulas do not interfere with iron absorption in premature infants
434. Plasma folate levels in preterm infants, with and without a 1 mg daily folate supplement
435. High folate intakes related to zinc status in preterm infants
436. An investigation of fetal growth using serial ultrasound data
437. Physiological information gained from studies on the life raft ration
438. Increased susceptibility of cellular membranes to the induction of oxidative stress after ingestion of high doses of fish oil: Effect of aging and protective action of d-α tocopherol supplementation
439. Development of mammalian sulfur metabolism: Absence of cystathionase in human fetal tissues
440. Protein intake of premature infants: A reply
441. Milk protein quantity and quality in low-birth-weight infants. III. Effects on sulfur amino acids in plasma and urine
442. Nutritional requirement for taurine in patients receiving long-term parenteral nutrition
443. Comments on LSRO report's recommendations on infant formula nutrient requirements
444. Chapter 23. Nutrition
445. Effect of postnatal steroid administration on serum vitamin A concentrations in newborn infants with respiratory compromise
446. Availability of milk folate. Studies with cow's milk in experimental folic acid deficiency
447. The rapid induction of liver cell death in rats fed a choline-deficient methionine-low diet
448. The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens
449. Rapid turnover transport proteins, plasma albumin, and growth in low birth weight infants
450. Effects of gestation age and birth weight in the concentration of carnitine in the umbilical plasma
451. Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity
452. Assessment of trace-element status
453. Changes in hair trace metal concentrations in some Canadian low birthweight infants
454. The dietary trace metal intake of some Canadian full-term and low birthweight infants during the first twelve months of infancy
455. Effects of the addition of nucleotides to an adapted milk formula on the microbial pattern of faces in at term newborn infants
456. Nucleotides and related compounds in human and bovine milks
457. Magnesium metabolism in preterm infants: Effects of calcium, magnesium, and phosphorus, and of postnatal and gestational age
458. Is carnitine essential in children?
459. Influence of diet on the occurrence of hyperphosphatemia and hypocalcemia in the newborn infant
460. Prenatal fluoride for growth and development: Part X
461. Intrauterine growth retardation: Standards for diagnosis
462. Clinical effects of two different levels of protein intake on low-birth-weight infants
463. Late effects of early dietary protein intake on low-birth-weight infants
464. Vitamin K-dependent clotting factors during long-term total parenteral nutrition in full-term and preterm infants
465. Human requirements for vitamin C and its use in clinical medicine
466. Tyrosinemia and related disorders
467. Bilirubin and ascorbate antioxidant activity in neonatal plasma
468. Respiratory metabolism in infancy and in childhood. XXIII. Daily energy requirements of premature infants
469. Feeding of premature infants: A comparison of human and cow's milk
470. On the uptake of materials by the intact liver. The transport and net removal of galactose
471. Starch digestion and absorption in nonruminants
472. Megaolblastic anaemia in premature infants
473. Guidelines for the use of vitamins, trace elements, calcium, magnesium, and phosphorus in infants and children receiving total parenteral nutrition: Report of the Subcommittee on Pediatric Parenteral Nutrient Requirements from the Committee on Clinical Practice Issues of the American Society for Clinical Nutrition
474. Persistently low blood retinol levels during and after parenteral feeding of very low birth weight infants: Examination of losses into intravenous administration sets and an method of prevention by addition to a lipid emulsion
475. Vitamins for newborn infant formulas: A review of recommendations with emphasis on data from low birth-weight infants
476. 6, niacin, pantothenic acid, and biotin
477. Intravenous vitamins for very-low-birth-weight infants
478. Immediate effects of albumin infusion in ill premature neonates
479. Calcium, phosphorus, and magnesium: How much is too much for infant formulas?
480. Bone mineralization in the fetus and infant
481. Osteopenia of prematurity
482. Vitamin K status of lactating mothers and their infants
483. Vitamin metabolism and requirements in the micropremie
484. An accurate and reproducible absorptiometric technique for determining bone mineral content in newborn infants
485. Improved bone mineralization and growth in premature infants fed fortified own mother's milk
486. Calcium, phosphorus, magnesium, and vitamin D requirements for the preterm infant
487. Estimation of fetal weight by ultrasound
488. Calcium absorption from milk in lactase-deficient subjects
489. Can the elimination of lactose from formula improve feeding tolerance in premature infants?
490. Hemolytic anemia in premature infants: Relationship to vitamin E, selenium, glutathione peroxidase, and erythrocyte lipids
491. Antioxidant relationship between selenium-dependent glutathione peroxidase and tocopherol
492. Vitamin E, red cell lipids and red cell stability in prematurity
493. Growth and biochemical response of preterm infants fed human milk or modified infant formula
494. Vitamin E
495. Nutritional composition of milk produced by mothers delivering preterm
496. Vitamin E status in preterm infants fed human milk or infant formula
497. Composition of breast milk from mothers of preterm infants
498. The dietary chloride deficiency syndrome
499. Taurine and cardiac physiology
500. Growth of the human fetus. I. Normal growth and its variation
501. Nonoliguric hyperkalemia in the premature infant weighing less than 1000 grams
502. Intravenous iron supplementation effect on tissue iron and hemoproteins in chronically phlebotomized lambs
503. Effect of chromium on glucose utilization in marasmic protein-calorie malnutrition
504. Effects of chromium supplementation on growth in marasmic protein-calorie malnutrition
505. Prediction of brain and serum free amino acid profiles in rats fed graded levels of protein
506. An evaluation of vitamin E status in premature infants
507. Arginine requirements in immature dogs
508. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Network
509. Catch-up growth during childhood among very low-birth-weight children
510. Sonographic estimation of fetal age and weight
511. In utero analysis of fetal growth: A sonographic weight standard
512. Taurine-deficient pigmented and albino rats: Early retinal abnormalities and differential rates of photoreceptor degeneration
513. Absorption of trace metals in the zincdeficient rat
514. Chromium and zinc contamination of parenteral nutrient solution components commonly used in infants and children
515. Feeding iron-fortified premature formula during initial hospitalization to infants less than 1800 grams birth weight
516. Copper and the preterm infant
517. Inositol supplementation in respiratory distress syndrome: Relationship between serum concentration, renal excretion, and lung effluent phospholipids
518. Inositol supplementation in premature infants with respiratory distress syndrome
519. Respiratory distress syndrome and inositol supplementation in preterm infants
520. Inositol supplementation in respiratory distress syndrome
521. Role of myoinositol in regulation of surfactant phospholipids in the newborn
522. Trace element requirements in premature infants
523. Zinc
524. Upper limits of zinc, copper and manganese in infant formulas
525. Human zinc deficiency
526. Physical growth: National Center for Health Statistics percentiles
527. The calcium and phosphorus metabolism of prematurely born infants
528. Fat needs for term and preterm infants
529. Introduction: Should infant formulas be supplemented with bioactive components and conditionally essential nutrients present in human milk? Given as part of the symposium "Bioactive components in milk and developments in milk and development of the neonate: Does their absence make a difference?" at Experimental Biology 96, April 17, 1996, Washington, DC
530. Gastric lipolysis and fat absorption in preterm infants: Effect of medium-chain triglyceride or long-chain triglyceride-containing formulas
531. Glucose inhibits myo-inositol uptake and reduces myo-inositol content in cultured rat glomerular mesangial cells
532. Amino acid and protein needs of the neonate: Effects of excess and deficiency
533. The relation of linoleic acid to infant feeding: A review
534. Challenges of matching human milk fatty acid patterns technically and functionally
535. Intrauterine growth
536. Treatment of diversion colitis with short-chain-fatty acid irrigation
537. Measurement of urinary electrolytes-indications and limitations
538. Effect of high dietary manganese on hemoglobin formation
539. Human milk nonprotein nitrogen components: Changing patterns of free amino acids and urea in the course of early lactation
540. Growth, zinc and copper nutritional status of male premature infants with different zinc intake
541. Effect of iron fortification of infant formula on trace mineral absorption
542. Syndrome in premature infants associated with low plasma vitamin E levels and high polyunsaturated fatty acid diet
543. Trace elements (copper, zinc, manganese, and selenium) in plasma and erythrocytes in relation to dietary intake during infancy
544. Erythrocyte manganese concentration in healthy Japanese children, adults, and the elderly, and in cord blood
545. High nutrient intakes-the toxicologist's view
546. Plasma amino acid concentrations in term-born infants fed a whey predominant or a whey hydrolysate formula
547. The formation of free and lipid myo-inositol in the intact rat
548. Patterns of metabolic adaptation for preterm and term infants in the first neonatal week
549. The effect of myo-inositol deficiency on lipid metabolism in rats. II. The mechanism of triacylglycerol accumulation in the liver of myo-inositol-deficient rats
550. The influence of sodium on growth in infancy
551. Retinal degeneration associated with taurine deficiency in the cat
552. Growth depression in taurine-depleted infant monkeys
553. Calcium metabolism in normal human pregnancy
554. Theoretical estimates of the protein requirements of children
555. Vitamin C supplementation increases low plasma vitamin C levels of premature infants fed human milk
556. Plasma vitamin C levels are low in premature infants fed human milk
557. Statistically significant versus biologically significant effects of long-chain polyunsaturated fatty acids on growth
558. Biological effects and safety issues related to long-chain polyunsaturated fatty acids in infants
559. Early use of parenteral amino acids
560. Nutrient utilization and growth in LBW infants
561. Hyperammonemia resulting from intravenous alimentation using a mixture of synthetic L-amino acids: A preliminary report
562. Total parenteral nutrition: The state of the art
563. Nutrition, growth, and body composition
564. 6 status associated with slow growth in healthy breast-fed infants
565. Studies on fluoride distribution in infants and small children
566. Adequacy of sulfur amino acid intake in infants receiving parenteral nutrition
567. Effect of intravenous L-carnitine on growth parameters and fat metabolism during parenteral nutrition in neonates
568. Enhanced lipid utilization in infants receiving oral L-carnitine during long-term parenteral nutrition
569. Evaluation of a subchronic (13-week) oral toxicity study, preceded by an in utero exposure phase, with arachidonic acid oil derived from Mortierella alpina in rats
570. Preliminary safety assessment of an arachidonic acid-enriched oil derived from Mortierella alpina: Summary of toxicological data
571. Effect of fish oil on the fatty acid composition of human milk and maternal and infant erythrocytes
572. Patterns of fetal and placental growth: The second half of normal pregnancy
573. Transitory hypertyrosinema of young infants and its relation to vitamin C
574. Vitamin B-12
575. Sodium, potassium and chloride needs in low-birth-weight infants
576. Intravenous glucose suppresses glucose production but not proteolysis in extremely premature newborns
577. Blood transfusion: Iron load and retinopathy of prematurity
578. A comparison of protein concentrations and energy in breast milk from preterm and term mothers
579. Effect of low-content zinc and copper formula on infant nutrition
580. Serial serum copper concentrations in premature and SGA infants during the first 3 months of life
581. Nutritional factors affecting mineral homeostasis and mineralization in the term and preterm infant
582. Osteopenia, hypocalcemia, and low 25-hydroxyvitamin D (25-OHD) serum concentration with use of soy formula
583. Mineral homeostasis in very premature infants: Serial evaluation of serum 25-hydroxyvitamin D, serum minerals, and bone mineralization
584. Measurement of true absorption, endogenous fecal excretion, urinary excretion, and retention of calcium in term infants by using a dual-tracer, stable-isotope method
585. Serial serum 25-hydroxyvitamin D and mineral homeostasis in very premature infants fed preterm human milk
586. Resistant cross-age smoothing of age-specific percentiles for growth reference data
587. Folate deficiency in premature infants
588. Analysis of birth weight, gestational age, and fetal viability U. S. births, 1968
589. The vitamin D content of fortified milk and infant formula
590. A case of human linolenic acid deficiency involving neurological abnormalities
591. Choline and choline esters in human and rat milk and in infant formulas
592. The choline content of human breast milk expressed during the first few weeks of lactation
593. Changes in the choline content of human breast milk in the first 3 weeks after birth
594. Metabolism and function of myo-inositol and inositol phospholipids
595. The nutritional importance of inositol and the phosphoinositides
596. The a-wave of the human electroretinogram and rod receptor function
597. Improvement of impaired carbohydrate metabolism by chromium III in manourished infants
598. Immunoreactivity for taurine in the cochlea: Its abundance in supporting cells
599. Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy
600. Taurine: An essential amino acid to prevent cholestasis in neonates?
601. Inositol for respiratory distress syndrome in preterm infants
602. Arachidonate and docosahexaenoate added to infant formula influence fatty acid composition and subsequent eicosanoid production in neonatal pigs
603. Triglycerides, fatty acids, sterols, mono- and disaccharides and sugar alcohols in human milk and current types of infant formula milk
604. Relationship of vitamin A (retinol) status to lung disease in the preterm infant
605. Selenium and vitamin E sufficiency in premature infants requiring total parenteral nutrition
606. Parenteral and eneteral selenium supplementation in low birthweight preterm infants
607. Selenium supplementation in low-birthweight premature infants: Relationship to trace metals and antioxidant enzymes
608. Nutrient and mineral retention and vitamin D absorption in low-birth-weight infants: Effect of medium-chain triglycerides
609. Relationship of antioxidant enzymes to trace metals in premature infants
610. Trends in maternal and infant health factors associated with low infant birth weight United States, 1972 and 1980
611. Does taurine have a function?
612. Physiological and experimental regulation of taurine content in the heart
613. 1H-spectroscopy in developing human brain
614. Reversal of developmental delays in iron-deficient anaemic infants treated with iron
615. Retinal morphology and visual pigment levels in 6- and 12-month-old Rhesus monkeys fed a taurine-free human infant formula
616. High iron status in very low birth weight infants is associated with an increased risk of retinopathy of prematurity
617. Determination of free myo-inositol in milk and infant formula by high-performance liquid chromatography
618. Ascorbic acid requirements in early infancy
619. Essential fatty acids in growth and development
620. Human milk and formula fatty acids
621. Fat
622. Visual acuity and blood lipids in term infants fed human milk or formulae
623. Selenium
624. Chapter 11. Molybdenum
625. Chapter 6. Chromium
626. Chapter 8. Iodine
627. Iron status in low birth weight infants on breast and formula feeding
628. The human arginases and arginase deficiency
629. Urinary excretion of 5-L-oxoproline (pyroglutamic acid) during early life in term and preterm infants
630. Vitamin C
631. Properties and distribution of mammalian L-cysteine sulfinate carboxy-lyases
632. Hypervitaminosis D associated with drinking milk
633. Zinc homeostasis in very low birth weight infants - A comparison of human milk and formulas
634. Trace elements in intravenous fluids
635. Effect of diet on term infant cerebral cortex fatty acid composition
636. Indices of protein metabolism in term infants fed either human milk or formulas with reduced protein concentration and various whey/casein ratios
637. Variation of serum ferritin in low birth weight infants with maternal ferritin, birth weight and gestational age
638. Iron, oxygen stress, and the preterm infant
639. Feeding the low-birth-weight infant: I. Taurine and cholesterol supplementation of formula does not affect growth and metabolism
640. Preterm infants fed human milk attain intrauterine weight gain
641. A longitudinal study of fetal weight growth
642. A longitudinal study of fetal head biometry
643. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition
644. Effect of 18:3ω3 intake on plasma fatty acids, growth and visual development of preterm infants
645. Effect of docosahexaenoic acid supplementation of lactating women on the fatty acid composition of breast milk lipids and maternal and infant plasma phospholipids
646. Effect of dietary linoleic/alpha-linolenic acid ratio on growth and visual function of term infants
647. Lipids in human milk
648. Milk lipids: Human milk lipids
649. Particulate constituents in human and bovine milks
650. The development of the functions of the small intestine of the human fetus
651. The new BPD: An arrest of lung development
652. Hyperammonemia accompanying parenteral nutrition in newborn infants
653. Homeostatic control of zinc metabolism in men: Zinc excretion and balance in men fed diets low in zinc
654. Visual acuity and erythrocyte docosahexaenoic acid status in breast-fed and formula-fed term infants during the first four months of life
655. Treatment of anaemia of infancy with iron and copper
656. Studies of immunomodulating actions of RNA/nucleotides. RNA/nucleotides enhance in vitro immunoglobulin production by human peripheral blood mononucleaar cells in response to T-dependent stimuli
657. The control of flux: 21 Years on
658. Do healthy premature infants fed breast milk need vitamin E supplementation: α- and γ-tocopherol levels in blood components and buccal mucosal cells
659. Galactose, glucose, and lactate concentrations in the portal venous and arterial circulations of newborn lambs after nursing
660. Metabolism of glucose in very-low-birth-weight infants
661. Carbohydrate as nutrient in the infant and child: Range of acceptable intake
662. 2, misoprostol or prostacyclir
663. 2 analogue effects on absorption, retention, and urinary excretion of 51 chromium
664. The effect of hyperalimentation on hepatic lipid content and lipogenic enzyme activity in rats and man
665. Threonine metabolism in vivo: Effect of threonine intake and prior induction of threonine dehydratase in rats
666. Vitamin B-6 adequacy in neonatal nutrition: Associations with preterm delivery, type of feeding, and vitamin B-6 supplementation
667. Serum antioxidant activity in permature babies
668. Effects of varying protein and energy intakes on growth and metabolic response in low birth weight infants
669. Protein requirements of low birthweight, very low birthweight, and small for gestational age infants
670. Protein quality in feeding low birth weight infants: A comparison of whey-predominant versus casein-predominant formulas
671. Growth, nutrient retention, and metabolic response of low-birth-weight infants fed supplemented and unsupplemented preterm human milk
672. Growth, nutrient retention, and metabolic response in low birth weight infants fed varying intakes of pretein and energy
673. Evaluation of a mathematical model for predicting the relationship between protein and energy intakes of low-birth-weight infants and the rate and composition of weight gain
674. Anthropometric assessment
675. The effect of medium and long chain triglyceride on human adipose tissue metabolism
676. Fat absorption in infants of birth weight less than 1,300 gm
677. The effect of age on manganese uptake and retention from milk and infant formulas in rats
678. Supplementation of milk with iron bound to lactoferrin using weanling mice. II: Effects on tissue manganese, zinc, and copper
679. Folic acid in low birthweight infants
680. Observations on effect of sodium selenite in prevention of Keshan disease
681. De novo synthesis of cysteine in premature neonates
682. Plasma carnitine levels in adult males in India: Effects of high cereal, low fat diet, fat supplementation, and nutrition status
683. Megaloblastic anemia in infancy and childhood in Djakarta
684. Colonic fermentation of carbohydrate in the premature infant: Possible relevance to necrotizing enterocolitis
685. Digestion, absorption, and fermentation of carbohydrates in the newborn
686. Lactose in formulas for preterm infants
687. In vivo estimation of lactose hydrolysis in premature infants using a dual stable tracer technique
688. Manifestations of chronic selenium deficiency in a child receiving total parenteral nutrition
689. Digestion, absorption, and fermentation of carbohydrates
690. Efficient assimilation of lactose carbon in premature infants
691. Contribution of low-molecular-weight compounds to the fecal excretion of carbohydrate energy in premature infants
692. Effects of lactose intake on nutritional status in premature infants
693. Dietary carbohydrate assimilation in the premature infant: Evidence for a nutritionally significant bacterial ecosystem in the colon
694. In vivo lactose digestion in preterm infants
695. Effects of lactose intake on lactose digestion and colonic fermentation in preterm infants
696. A method for assessing carbohydrate energy absorption and its application to premature infants
697. Mild peripheral neuropathy but biochemical chromium sufficiency during 16 months of "chromium-free" total parenteral nutrition
698. Phenylalanine hydroxylase activity in preterm infants: Is tyrosine a conditionally essential amino acid?
699. Regulation of glucose production in newborn infants of diabetic mothers
700. Cerebral metabolic rate for glucose during the first six months of life: An FDG positron emission tomography study
701. Biliary flow rate and concentration of Fe, Cu and Mn as affected by enteral or parenteral Ni supply
702. Changes in the metabolism (retention, absorption, excretion) of copper, zinc, and manganese in gravidity and lactation
703. Absorption of zinc and manganese in relation to age
704. Historical perspectives on our understanding of vitamin B-6 in pregnancy, lactation, and infancy
705. The effect of enteric galactose on neonatal canine carbohydrate metabolism
706. Perinatal galactose metabolism
707. Taurine: An essential nutrient for the cat
708. Zinc and manganese bioavailability from human milk and infant formula used for very low birth-weight infants, evaluated in a rat pup model
709. Trans fatty acids and the human infant
710. Fat content and fatty acid composition of infant formulas
711. Fatty acid composition of mature human milk in Germany
712. Intestinal milk-bolus obstruction in formula-fed premature infants given high doses of calcium
713. Tremor and seizures associated with chronic manganese intoxication
714. Effects of manganese forms on biogenic amines in the brain and behavioral alterations in the mouse: Long-term oral administration of several manganese compounds
715. Possible health effects of high manganese concentration in drinking water
716. Postnatal development of bone mineral status during infancy
717. Breast milk sodium
718. Effect of three levels of vitamin D intake in preterm infants receiving high mineral-containing milk
719. Effect of different vitamin A intakes on very-low-birth-weight infants
720. Serum vitamin D metabolites in very low birth weight infants with and without rickets and fractures
721. Osteopenia and rickets of prematurity
722. Calcium, magnesium, phosphorus, and vitamin D
723. Building better bones: Calcium, magnesium, phosphorus, and vitamin D
724. Calcium and magnesium homeostasis
725. Fluoride levels in breast milk and infant foods
726. Influence of age on metal metabolism and toxicity
727. The effect of iron additive to milk on cadmium, mercury, and manganese absorption in rats
728. Concentrations of selected trace elements in human milk and in infant formulas determined by magnetic sector field inductively coupled plasma-mass spectrometry
729. Relationship of vitamin A and vitamin E intake to fasting plasma retinol, retinol-binding protein, retinyl esters, carotene, α-tocopherol, and cholesterol among elderly people and young adults: Increased plasma retinyl esters among vitamin A-supplement users
730. Zinc requirements and zinc intakes of breast-fed infants
731. Zinc homeostasis in breast-fed infants
732. Vitamin B-6 requirement and status assessment: Young women fed a depletion diet followed by a plant- or animal-protein diet with graded amounts of vitamin B-6
733. Chapter 11. Parenteral nutrition: Vitamins, minerals, and trace elements
734. Influence of dietary nucleotide restriction on bacterial sepsis and phagocytic cell function in mice
735. The role of dietary sources of nucleotides in immune function: A review
736. Selenium status of exclusively breast-fed infants as influenced by maternal organic or inorganic selenium supplementation
737. The glucose-galactose paradox in neonatal murine hepatic glycogen synthesis
738. Carbohydrate supplementation of human milk to promote growth in preterm infants
739. Delay of catch-up growth in very low birthweight infants
740. Copper status of very low birth weight infants during the first 12 months of infancy
741. Gestational age-dependent reference values for iron and selected proteins of iron metabolism in serum of premature human neonates
742. New deficiency syndrome occurring in infancy
743. Enamel hypoplasia and dental caries in very-low birthweight children: A case-controlled, longitudinal study
744. Cysteine usage increases the need for acetate in neonates who receive total parenteral nutrition
745. Riboflavin metabolism - Relevance to human nutrition
746. Vitamins D and E in human milk
747. Comparison of enteral and intramuscular vitamin A supplementation in preterm infants
748. Mineral balance and whole body bone mineral content in very low-birth-weight infants
749. 59Fe
750. Dental fluorosis in the primary and the permanent dentition in fluoridated areas with consumption of either powdered milk or natural cow's milk
751. Normal fetal growth evaluated by longitudinal ultrasound examinations
752. Amino acids as volume-regulatory osmolytes in mammalian cells
753. Total potentially available nucleosides of human milk by stage of lactation
754. Food-processing approaches to altering allergenic potential of milk-based formula
755. Lipid peroxidation in rat tissue slices: Effect of dietary vitamin E, corn oil-lard and menhaden oil
756. 6
757. 6
758. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996
759. Differences in the composition of preterm and term human milk during early lactation
760. Studies on the enhancement of radiocalcium and radiostrontium absorption by lactose in the rat
761. Early neonatal hyperkalaemia in the extremely premature newborn infant
762. Behavioral and psychophysiologic assessment of the preterm infant
763. Upper limit of selenium in infant formulas
764. Selenium
765. Electrical activity across human foetal small intestine associated with absorption processes
766. Controlled trials of inositol in psychiatry
767. Inositol treatment of autism
768. Double-blind, controlled trial of inositol treatment of depression
769. Vitamin C
770. A defect in the metabolism of tyrosine and phenylalanine in premature infants. II. Spontaneous occurrence and eradication by vitamin C
771. A defect in the metabolism of aromatic amino acids in premature infants: The role of vitamin C
772. 12 status of low birth weight infants receiving parenteral and enteral nutrition
773. Copper deficiency in infants fed cow milk
774. Myoinositol in human neonates: Serum concentrations and renal handling
775. Studies of babies born at high altitude
776. Aminoacidemia of prematurity: Its response to ascorbic acid
777. Clinical significance of tyrosinemia of prematurity
778. Measurable folates in human milk are increased by treatment with α-amylase and protease
779. Diminished protection against copper-induced lipid peroxidation by cord blood plasma of preterm and term infants
780. The total free radical trapping ability of cord blood plasma in preterm and term babies
781. Selenium in pediatric nutrition
782. Selenium status in term infants fed human milk or infant formula with or without added selenium
783. Morphologic study of development of cerebral cortex of therapeutically aborted fetuses in endemic goiter region, Gui-Zhou province, China
784. Serum zinc, copper, retinol-binding protein, prealbumin, and ceruloplasmin concentrations in infants receiving intravenous zinc and copper supplementation
785. Selenium deficiency in low birth weight neonates: An unrecognized problem
786. Carnitine status of lactoovovegetarians and strict vegetarian adults and children
787. Selenium content of human milk, cow's milk and cow's milk infant formulas
788. Trace elements in the perinatal period
789. Trace element absorption in infants as a foundation setting upper limits for trace elements in infant formulas
790. Bioavailability of copper
791. Copper nutrition during infancy and childhood
792. Calcium, iron, zinc, copper and manganese bioavailability from infant formulas and weaning diets assessed in rat pups
793. Prevalence of iron deficiency in the United States
794. Nutritional anemia. VI. Fetal hepatic storage of metabolites in the second half of pregnancy
795. Epidemiology of late onset haemorrhagic disease: A pooled data analysis
796. Late onset haemorrhagic disease in premature infants who received intravenous vitamin K1
797. 2 dust
798. Choline-induced spatial memory facilitation correlates with altered distribution and morphology of septal neurons
799. Iron deficiency anemia and iron therapy effects on infant developmental test performance
800. Long-term developmental outcome of infants with iron deficiency
801. Behavior of infants with iron-deficiency anemia
802. Intrauterine growth as estimated from liveborn birth-weight data at 24 to 42 weeks of gestation
803. Does early diet program future outcome?
804. Enteral nutrition
805. Long-chain polyunsaturated fatty acids, infant feeding and cognitive development
806. Occurrence and significance of riboflavin deficiency in preterm infants
807. Randomised trial of nutrition for preterm infants after discharge
808. Early diet of preterm infants and development of allergic or atopic disease: Randomized prospective study
809. Randomized outcome trial of human milk fortification and developmental outcome in preterm infants
810. Multicentre trial on feeding low birthweight infants: Effects of diet on early growth
811. Randomised trial of early diet in preterm babies and later intelligence quotient
812. Early diet in preterm babies and developmental status at 18 months
813. Randomised controlled trial of a synthetic triglyceride milk formula for preterm infants
814. Low plasma triiodothyronine concentrations and outcome in preterm infants
815. Efficacy and safety of long-chain polyunsaturated fatty acid supplementation of infant-formula milk: A randomised trial
816. At what age does iron supplementation become necessary in low-birth-weight infants?
817. Serum sodium concentration and intraventricular hemorrhage in premature infants
818. Influence of luminal pH on rat large bowel epithelial cell cycle
819. Calcium and phosphorus balance in extremely low birthweight infants in the first six weeks of life
820. Developmental microbial ecology of the neonatal gastrointestinal tract
821. Iron deficiency in the rat: Effects on oxidative metabolism in distinct types of skeletal muscle
822. Fat, calcium and nitrogen balance in full-term infants
823. The electroretinogram in preterm infants
824. Inhibition of desaturation of palmitic, linoleic and eicosa-8,11,14-trienoic acids in vitro by isomeric cisoctadecenoic acids
825. The effect of isomeric trans-18:1 acids on the desaturation of palmitic, linoleic and eicosa-8, 11, 14-trienoic acids by rat liver microsomes
826. High-versus low-dose erythropoietin in extremely low birth weight infants
827. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants
828. Effect of maternal docosahexaenoic acid (DHA) supplementation on breast milk composition
829. A critical appraisal of the role of dietary long-chain polyunsaturated fatty acids on neural indices of term infants: A randomized, controlled trial
830. Total parenteral nutrition in sick preterm infants: Effects of cysteine supplementation with nitrogen intakes of 240 and 400 mg/kg/day
831. Intellectual deficits after transient tyrosinemia in the term neonate
832. Serum copper concentrations in sick and well preterm infants
833. Alimentärer chloridmangel bei frügeborenen?
834. Intermittent high-dose vitamin D prophylaxis during infancy: Effect on vitamin D metabolites, calcium, and phosphorus
835. The development of children with transient neonatal tyrosinemia
836. Dietary nucleotides might influence the humoral immune response against cow's milk proteins in preterm neonates
837. Tissue levels of polyunsaturated fatty acids during early human development
838. Illness with fatalities in premature infants: Association with an intravenous vitamin E preparation, E-Ferol
839. Retention of selenium (Se) from vitamin/mineral (V/M) premix and infant formulas
840. The plasma tyrosine levels of premature babies
841. Comparison of the effects of L-carnitine, D-carnitine and acetyl-L-carnitine on the neurotoxicity of ammonia
842. Grating acuity cards: Validity and reliability in studies of human visual development
843. Calcium and phosphorus metabolism in the premature infant
844. Long-chain polyunsaturated fatty acids and the measurement and prediction of intelligence (IQ)
845. Two interconnected B vitamins: Riboflavin and pyridoxine
846. Water-soluble vitamins: Bases for suggested upper limits for infant formulas
847. Riboflavin
848. Update on interconversions of vitamin B-6 with its coenzyme
849. Vitamin B-6 intake and whole blood levels of breast and formula fed infants: Serial whole blood vitamin B-6 levels in premature infants
850. Vitamin B-6 status of Egyptian mothers: Relation to infant behavior and maternal-infant interactions
851. The acuity card procedure: A rapid test of infant acuity
852. Outcomes at 18 months corrected age of very low birth weight (VLBW) infants who received human milk during hospitalization
853. Assessment of rat growth methods for estimating protein quality: Interlaboratory study
854. Serum copper and zinc levels in the preterm infant. A longitudinal study of the first year of life
855. The influence of gestational age and size on the absorption of D-xylose and D-glucose from the small intestine of the human neonate
856. Pre- and postnatal choline supplementation produces long-term facilitation of spatial memory
857. Organizational changes in cholinergic activity and enhanced visuospatial memory as a function of choline administered prenatally or postnatally or both
858. Transient hypothyroxinaemia associated with developmental delay in very preterm infants
859. Contents of trace elements in the human liver before birth
860. Generation of hydroxytrimethyllysine from trimethyllysine limits the carnitine biosynthesis in premature infants
861. Effects of oral L-carnitine supplementation in low-birth-weight premature infants maintained on human milk
862. Vitamin E-dependent anemia in the premature infant. I. Effects of large doses of medicinal iron
863. Chapter 7. Manganese
864. Chapter 6. Manganese
865. Chronic manganese poisoning. Individual susceptibility and absorption of iron
866. Zinc, copper and iron content of milk from mothers of preterm and full-term infants
867. The metabolism of phenylalanine and tyrosine in the premature infant
868. Effect of elevated blood tyrosine on subsequent intellectual development of premature infants
869. Relationship of elevated blood tyrosine to the ultimate intellectual performance of premature infants
870. Trans monounsaturated fatty acids in nutrition and their impact on serum lipoprotein levels in man
871. Effect of dietary cis and trans fatty acids on serum lipoprotein[a] levels in humans
872. Chromium occurrence and function in biological systems
873. Use and misuse of balance studies
874. Chromium in human nutrition: A review
875. Serum ferritin in term and preterm infants
876. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin
877. Recombinant human erythropoietin in the treatment of the anemia of prematurity: Results of a double-blind, placebo-controlled study
878. Protein
879. Size of the zinc pools that exchange rapidly with plasma zinc in humans: Alternative techniques for measuring and relation to dietary zinc intake
880. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates
881. Decreased cysteine and proline synthesis in parenterally fed, premature infants
882. Compartmentation of endogenously synthesized amino acids in neonates
883. Problems with human milk and infant formulas
884. Control of tissue manganese: Initial absence and sudden emergence of excretion in the neonatal mouse
885. Chapter 13. Molybdenum
886. An analysis of birth weight by gestational age of infants born in England and Wales, 1967 to 1971
887. Hypertyrosinemia
888. Cerebral intraventricular hemorrhages in infants: A widening age spectrum
889. Effect of phosphorus supply on mineral balance at high calcium intakes in very low birth weight infants
890. Biotin deficiency: An unusual complication of parenteral alimentation
891. The method of intraluminal perfusion of the human small intestine. II. Absorption studies in health
892. Longitudinal study of fetal growth in subgroups of a low-risk population
893. Fluorine in parenteral nutrition solutions
894. Utilization of supplemental iron by premature infants fed fortified human milk
895. Evaluation of a pediatric multiple vitamin preparation for total parenteral nutrition in infants and children. I. Blood levels of water-soluble vitamins
896. Cerebral endothelium and astrocytes cooperate in supplying docosahexaenoic acid to neurons
897. Astrocytes, not neurons, produce docosahexaenoic acid (22:6 ω-3) and arachidonic acid (20:4 ω-6)
898. The B vitamins and vitamin C in human nutrition. II. 'Conditional' B vitamins and vitamin C
899. Vitamin requirements
900. Lipoprotein changes in small-for-gestational-age infants fed nucleotide-supplemented milk formula
901. Randomized diet in the neonatal period and growth performance until 7.5-8 y of age in preterm children
902. Growth and plasma amino acid concentrations in very low birthweight infants fed either human milk protein fortified human milk or a whey-predominant formula
903. Fortification of human milk
904. Growth and metabolic responses in low-birth-weight infants fed human milk fortified with human milk protein or with a bovine milk protein preparation
905. Relationship between protein and energy in the feeding of preterm infants during the first month of life
906. Fortification of human milk: Evaluation of a novel fortification scheme and of a new fortifier
907. Regulation of enzymes of urea and arginine synthesis
908. Breastfeeding and cognitive development in the first 2 years of life
909. Dicarboxylic acids and the lipid metabolism
910. Effect of oxygen on lung superoxide dismutase activities in premature baboons with bronchopulmonary dysplasia
911. Effects of two levels of intake of chloride, potassium, and calcium on mineral and acid-base metabolism in premature infants
912. Calcium and magnesium dietary intakes and plasma and milk concentrations of Nepalese lactating women
913. Prealbumin as a biochemical marker of nutritional adequacy in premature infants
914. Excessive chromium intake in children receiving total parenteral nutrition
915. Short-term polycose substitution for lactose reduces calcium absorption in healthy term babies
916. Role of calcium-phosphate ratio of milk formulae on calcium balance in low weight infants during the first three days of life
917. A metabolic balance study in term infants fed lactose-containing or lactose-free formula
918. Effect of excess levels of individual amino acids on growth of rats fed casein diets
919. Zinc deficiency: A problem with preterm breast milk
920. Distortions in fetal growth standards
921. Neuronal-glial exchange of taurine during hypo-osmotic stress: A combined immunocytochemical and biochemical analysis in rat cerebellar cortex
922. S-potentials from colour units in the retina of fish (cyprinidae)
923. Carnitine concentration during the development of human tissues
924. Neutral oligosaccharide content of preterm human milk
925. Hypervitaminosis D after prolonged feeding with a premature formula
926. Collaborative care
927. Bone mineralization status measured by dual energy radiographic densitometry in preterm infants fed commercial formulas
928. Special Report. Safe practices for parenteral nutrition formulations
929. Vitamin K
930. Influence of dietary nucleotides on plasma immunoglobulin levels and lymphocyte subsets of preterm infants
931. Serum vitamin E levels in the very low birth weight infant during oral supplementation
932. Biochemical and functional effects of prenatal and postnatal ω3 fatty acid deficiency on retina and brain in Rhesus monkeys
933. Dietary omega-3 fatty acid deficiency and visual loss in infant Rhesus monkeys
934. Visual acuity loss in Rhesus monkey infants fed a taurine-free human infant formula
935. Labile methyl groups and the promotion of cancer
936. Carbohydrates in milks: Analysis, quantities, and significance
937. Mother's milk for preterm infants
938. Breath hydrogen excretion in healthy premature infants
939. Ultratrace minerals
940. Chapter 16. Ultratrace Minerals
941. Growth until 3 years of age in a prospective, randomized trial of a diet with reduced saturated fat and cholesterol
942. Regulation of growth of 7- to 36-month old children by energy and fat intake in the prospective, randomized STRIP Baby Trial
943. Determinants of energy, protein, lipid, and lactose concentrations in human milk during the first 12 mo of lactation: The DARLING Study
944. Spatial frequency sweep VEP: Visual acuity during the first year of life
945. The effect of a L-carnitine supplemented soybean formula on the plasma lipids of infants
946. L-carnitine supplementation of a soybean-based formula in early infancy: Plasma and urine levels of carnitine and acylcarnitines
947. Carnitine in the perinatal metabolism of lipids. I. Relationship between maternal and fetal plasma levels of carnitine and acylcarnitines
948. Effect of carnitine on lipolysis in subcutaneous adipose tissue of newborns
949. Urea cycle enzyme adaptation to dietary protein in primates
950. Zinc deficiency in rapidly growing preterm infants
951. Folate status during pregnancy and lactation
952. Maternal folate status and lactation
953. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: A prospective randomized control trial
954. Pteroylpolyglutamates in human milk
955. Ascorbic acid promotes Cr absorption
956. Chromium in human nutrition
957. The content of free and bound inositol in human and cow's milk
958. L-carnitine protection in ammonia intoxication: Effect of aminocarnitine on carnitine-dependent metabolism and acute ammonia toxicity
959. Use of medium-chain triglycerides in feeding the low-birth-weight infant
960. Competitive inhibition by glucose of myo-inositol incorporation into cultured porcine aortic endothelial cells
961. Low carnitine intake and altered lipid metabolism in infants
962. γ-butyrobetaine hydroxylase activity is not rate limiting for carnitine biosynthesis in the human infant
963. Renal conservation of carnitine by infants and adults: No evidence of developmental regulation
964. Upper limits of vitamin A in infant formulas, with some comments on vitamin K
965. Selenium toxicity in animals with emphasis on man
966. Vitamin K
967. Prolonged feeding studies in premature infants
968. Neonatal rickets. Histopathology and quantitative bone changes
969. Vitamins for very low birthweight infants
970. Effect of iron therapy on behavior performance in nonanemic, iron-deficient infants
971. Intrauterine growth retardation and preterm delivery
972. Children of deviant birthweight at the age of seven years: Health, handicap, size and developmental status
973. Standards for ultrasound fetal growth velocity
974. Laminar analysis of the number of neurons, astrocytes, oligodendrocytes and microglia in the visual cortex (area 17) of 6- and 12-month-old Rhesus monkeys fed a human infant soy-protein formula with or without taurine supplementation from birth
975. Dietary fats, membrane phospholipids and obesity
976. The influence of protein intake on vitamin B-6 metabolism differs in young and elderly humans
977. Vitamin E and linoleic acid in the feeding of premature infants
978. Chapter 26. The extremely-low-birth-weight infant
979. The recognition of scurvy with special reference to the early X-ray changes
980. Stool water in preterm neonates
981. Neonatal tyrosinaemia: A follow-up study
982. Glycerol metabolism and triglyceride-fatty acid cycling in the human newborn: Effect of maternal diabetes and intrauterine growth retardation
983. 12 and folic acid values in premature infants
984. Chromium content of infant formula as determined by isotope dilution/mass spectrometry
985. Vitamin A status of preterm infants during infancy
986. Protein metabolism in human neonates: Nitrogen-balance studies, estimated obligatory losses of nitrogen and whole-body turnover of nitrogen
987. Risk factors for enamel fluorosis in optimally fluoridated children born after the US manufacturers' decision to reduce the fluoride concentration of infant formula
988. Food intake regulation: Amino acid toxicity and changes in rat brain and plasma amino acids
989. Carnitine concentrations in the milk of different species and infant formulas
990. Effect of nutrition on tissue carnitine concentrations in infants of different gestational ages
991. Decreased tissue carnitine concentrations in newborn infants receiving total parenteral nutrition
992. Serum myoinositol concentrations in premature infants fed human milk, formula for infants, and parenteral nutrition
993. Taurine and auditory system maturation
994. Chronic vitamin A intoxication during the first half year of life: Description of 5 cases
995. Intra-uterine weight curves obtained by ultrasound
996. L-arginine supplementation increases mesangial cell injury and subsequent tissue fibrosis in experimental glomerulonephritis
997. Iodine deficiency disorders
998. Tocopherol efficacy and safety for preventing retinopathy of prematurity: A randomized, controlled, double-masked trial
999. Fluoride
1000. Folate nutrition in infancy
1001. Folate nutrition in lactation
1002. Myocardial failure in cats associated with low plasma taurine: A reversible cardiomyopathy
1003. Changes in the fatty acids pattern of red blood cell phospholipids induced by type of milk, dietary nucleotide supplementation, and postnatal age in preterm infants
1004. Trace element metabolism in the fetus and neonate
1005. Cystine: A semi-essential amino acid in the newborn infant
1006. Prevention of postnatal bone demineralization in very low-birth-weight infants by individually monitored supplementation with calcium and phosphorus
1007. Bone mineral content of appropriate and light for gestational age preterm and term newborn infants
1008. Amino acids do not suppress proteolysis in premature neonates
1009. Effect of infant formula zinc and iron level on zinc absorption, zinc status, and immune function in infant Rhesus monkeys
1010. Individualized protein fortification of human milk for preterm infants: Comparison of ultrafiltrated human milk protein and a bovine whey fortifier
1011. Growth of very low birth weight infants on varying amounts of human milk protein
1012. Amino acid concentrations in plasma and urine in very low birth weight infants fed protein-unenriched or human milk protein-enriched human milk
1013. Urinary and serum urea as indicators of protein metabolism in very low birthweight infants fed varying human milk protein intakes
1014. Eleven plasma proteins as indicators of protein nutritional status in very low birth weight infants
1015. Docosahexaenoic acid status of term infants fed breast milk or infant formula containing soy oil or corn oil
1016. Plasma and urine riboflavin and pyridoxine concentrations in enterally fed very-low-birth-weight neonates
1017. Comments
1018. Current knowledge concerning optimum nutritional status of riboflavin, niacin and pyridoxine
1019. Does vitamin C intake influence the rate of tyrosine catabolism in premature babies?
1020. Evaluation of methods for assessing visual function of infants
1021. Energy
1022. Supplementation of pooled human milk with casein hydrolysate: Energy and nitrogen balance and weight gain composition in very low birth weight infants
1023. Nutrient balance, energy utilization, and composition of weight gain in very-low-birth-weight infants fed pooled human milk or a preterm formula
1024. MRI in children receiving total parenteral nutrition
1025. Do infants need nucleotide supplemented formula for optimal nutrition?
1026. Comparative biological availability of manganese from extrinsically labelled milk diets using sucking rats as a model
1027. Milk protein quantity and quality in human milk and infant formulae
1028. Protein fortification of human milk for feeding preterm infants
1029. Milk protein quantity and quality in low-birthweight infants: I. Metabolic responses and effects on growth
1030. Phenylalanine hydoxylase in human liver during development
1031. Biochemical basis for nutritional management of preterm infants
1032. 6 metabolism in premature infants
1033. Assessment of nutrient requirements for infant formulas
1034. Assessment of nutrient requirements for infant formulas
1035. Vitamin dependent erythrocyte enzymes in newborns in relation to gestational age and birth weight
1036. Taurine concentrations in the diet, plasma, urine and breast milk of vegans compared with omnivores
1037. Essential and non-essential amino acids in neonatal nutrition
1038. Milk protein quantity and quality in low-birth-weight infants: II. Effects on selected aliphatic amino acids in plasma and urine
1039. Feeding the low-birth-weight infant: II. Effects of taurine and cholesterol supplementation on amino acids and cholesterol
1040. Milk protein quantity and quality in low-birth weight infants. IV. Effects on tyrosine and phenylalanine in plasma and urine
1041. Clinical and metabolic considerations affecting vitamin B-6 status of premature infants
1042. Taurine and cholesterol supplementation in the term infant: Responses of growth and metabolism
1043. Taurine and other free amino acids in milk of man and other mammals
1044. The importance of selenium to human health
1045. Carnitine function and requirements during the life cycle
1046. Renal adaptation to dietary carnitine in humans
1047. Role of carnitine in utilization of dietary medium-chain triglycerides by term infants
1048. Carnitine metabolism and its regulation in microorganisms and mammals
1049. Threoninemia - A new metabolic defect
1050. Hyponatraemia in the first week of life in preterm infants. Part II. Sodium and water balance
1051. Diet, fat accretion, and growth in premature infants
1052. Partition of energy metabolism and energy cost of growth in the very low-birth-weight infant
1053. Microminerals
1054. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age
1055. Manganese in long term paediatric parenteral nutrition
1056. Vitamin B-6 requirement of elderly men and women
1057. Transient neonatal tyrosinaemia
1058. Purification of phosphatidylethanolamine N-methyltransferase from rat liver
1059. Nutritional evaluation of protein hydrolysate formulas
1060. Optimal threonine intake for preterm infants fed on oral or parenteral nutrition
1061. Significance of plasma amino acid pattern in preterm infants
1062. Metabolic balance studies and plasma amino acid concentrations in preterm infants fed experimental protein hydrolysate preterm formulas
1063. The absorption of iron as supplements in infant cereal and infant formulas
1064. Diet-induced changes in liver and bile but not brain fatty acids can be predicted from differences in plasma phospholipid fatty acids in formula- and milk-fed piglets
1065. Edema and hemolytic anemia in premature infants
1066. Safety of high-level vitamin C ingestion
1067. Riboflavin
1068. Folate state of premature infants
1069. Phenylalanine and tyrosine metabolism in neonates receiving parenteral nutrition differing in pattern of amino acids
1070. Effects of increased dietary phosphorus on magnesium balance in very low birthweight babies
1071. Biochemical features of dietary chloride deficiency syndrome: A comparative study of 30 cases
1072. Zinc and copper in hair and plasma of children with chronic diarrhea
1073. Utilization of nutrients by isolated epithelial cells of the rat colon
1074. Randomised trial of iodine intake and thyroid status in preterm infants
1075. Breast-feeding and cognitive development
1076. The influence of folic acid supplement on the outcome of pregnancies in the county of Funen in Denmark. Part I
1077. Evidence of altered central nervous system development in infants with iron deficiency anemia at 6 mo: Delayed maturation of auditory brainstem responses
1078. Human milk protein and medium-chain triglyceride oil supplementation of human milk: Plasma amino acids in very low-birth-weight infants
1079. Human milk protein supplementation for the prevention of hypoproteinemia without metabolic imbalance in breast milk-fed, very low-birth-weight infants
1080. Need for riboflavin supplementation in small prematures fed with human milk
1081. Vitamin E supplementation in very-low-birth-weight infants: Long-term follow-up at two different levels of vitamin E supplementation
1082. Supplementation with human milk protein improves growth of small premature infants fed human milk
1083. Low thyroxinaemia occurs in the majority of very preterm newborns
1084. Inositol prevents expression of a genetic model of neural tube defects in mice
1085. Serial trypsin inhibitory capacity and ceruloplasmin levels in prematures at risk for bronchopulmonary dysplasia
1086. Comments on FDA Docket No 96N-0391
1087. Vitamin A and retinoids
1088. Growth achievement of very low birth weight premature children at school age
1089. Competitive inhibition of iron absorption by manganese and zinc in humans
1090. Effect of a reduced vitamin K supplementation on prothrombin time in prematures and high-risk neonates
1091. Selenium: Biochemical role as a component of glutathione peroxidase
1092. Effect of high calcium and phosphorus intake on mineral retention in very low birth weight infants chronically treated with furosemide
1093. Achievement of in utero retention of calcium and phosphorus accompanied by high calcium excretion in very low birth weight infants fed a fortified formula
1094. Late hyponatremia in very low birthweight infants. (lt;1.3 kilograms)
1095. Hypokalemic metabolic alkalosis in normotensive infants with elevated plasma renin activity and hyperaldosteronism: Role of dietary chloride deficiency
1096. Urinary excretion of lactose and oligosaccharides in preterm infants fed human milk or infant formula
1097. Reference values for the trace elements copper, manganese, selenium, and zinc in the serum/plasma of children, adolescents, and adults
1098. Proteins: Biochemistry and applications
1099. Rapid lipid peroxidation in the nuclear fraction of rat liver induced by a diet deficient in choline and methionine
1100. Effect of DHA-containing formula on growth of preterm infants to 59 weeks prostmenstrual age
1101. Preparation and properties of the major copper-binding component in human fetal liver. Its identification as metallothionein
1102. Urine solute excretion in growing low-birth-weight infants
1103. Rumen epithelial cell proliferation accelerated by rapid increase in intraruminal butyrate
1104. Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants
1105. Calcium, phosphorus, and vitamin D requirements of premature infants
1106. Calcium, phosphorus, magnesium, and vitamin D requirements in premature infants
1107. Effects of calcium and phosphorus supplementation on calcium retention and fat absorption in preterm infants fed pooled human milk
1108. Nutrition of the low birthweight infant
1109. Cu nutrition in infants during prolonged exclusive breast-feeding: Low intake but rising serum concentrations of Cu and ceruloplasmin
1110. Plasma zinc concentrations in iron supplemented low birthweight infants
1111. Manganese balance studies in infants after operations on the heart
1112. Dietary nucleotides influence lipoprotein metabolism in newborn infants
1113. Dietary nucleotides enhance plasma lecithin cholesterol acyl transferase activity and apolipoprotein A-IV concentration in preterm newborn infants
1114. The influence of a vegetarian diet on the fatty acid composition of human milk and the essential fatty acid status of the infant
1115. On carnitine content of the human breast milk
1116. Deliberations and evaluations of approaches, endpoints and paradigms for determining zinc dietary recommendations
1117. Manganese absorption and metabolism in man
1118. Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants
1119. Comparison of the composition of breast milk from mothers of term and preterm infants
1120. Effect of phosphate supplementation to breast fed very low birth-weight infants on urinary calcium excretion, serum immunoreactive parathyroid hormone and plasma 1,25-dihydroxy-vitamin D concentration
1121. Chapter 16. Human milk and enteral nutrition products
1122. Amino acid rating method for evaluating protein adequacy of infant formulas
1123. Digestibility of protein and amino acids in selected foods as determined by a rat balance method
1124. Internal potassium shift in premature infants: Cause of nonoliguric hyperkalemia
1125. Rapid in-vitro assays for estimating protein quality
1126. Studies on the toxicity and antagonism of amino acids for weanling rats
1127. Interaction of vitamin B-6 with other nutrients
1128. Longitudinal studies on metabolic rate, heat loss, and energy cost of growth in low birth weight infants
1129. 13C]glucose
1130. Effect of dietary α-linolenic acid intake on incorporation of docosahexaenoic and arachidonic acids into plasma phospholipids of term infants
1131. Intermediates in endogenous synthesis of C22:6 ω3 and C20:4 ω6 by term and preterm infants
1132. Adenine, the precursor of nucleic acids in intestinal cells unable to synthesize purines de novo
1133. Functional characterization of the carnitine transporter defective in primary carnitine deficiency
1134. 6, Niacin, Biotin, and Pantothenic Acid
1135. Human milk for preterm infants: Nutritional and immune factors
1136. Suitability of human milk for the low-birthweight infant
1137. Who needs water-soluble vitamins?
1138. Clinical benefits of human milk for premature infants
1139. Postnatal attainment of intrauterine macromineral accretion rates in low birth weight infants fed fortified human milk
1140. Bioavailability of calcium and phosphorus in human milk fortifiers and formula for very low birth weight infants
1141. Effects of nutrients in human milk on the recipient premature infant
1142. Rationale for breast-feeding
1143. Improved mineral balance in very low birth weight infants fed fortified human milk
1144. Fortified mothers' milk for very low birth weight infants: Results of growth and nutrient balance studies
1145. Fortified mothers' milk for very low birth weight infants: Results of macromineral balance studies
1146. Human milk for the hospitalized preterm infant
1147. 6, and niacin
1148. Calcium, phosphorus and magnesium needs for the low-birth-weight infant
1149. Feeding strategies for premature infants: Beneficial outcomes of feeding fortified human milk versus preterm formula
1150. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome
1151. Plasma carnitine levels during intravenous feeding of the neonate
1152. Carnitine and development of newborn adipose tissue
1153. Carnitine deficiency in premature infants receiving total parenteral nutrition: Effect of L-carnitine supplementation
1154. Dietary and serum folate: Their influence on the outcome of pregnancy
1155. Importance of adequate folate nutrition in embryonic and early fetal development
1156. Lack of lactobezoars in infants given predominantly whey protein formulas
1157. Essential trace metals in man: Manganese. A study in homeostasis
1158. Effect of lactose or its component sugars on jejunal calcium absorption in adult man
1159. Accuracy of estimated fetal weight below 1,000 g
1160. Growth velocity and plasma amino acids in the newborn
1161. Tyrosine
1162. Effects of starch, sucrose, fructose and glucose on chromium absorption and tissue concentrations in obese and lean mice
1163. 51Chromium
1164. Effects of ascorbic acid depletion and chromium status on retention and urinary excretion of chromium
1165. Birthweight-for-gestational age charts based on early ultrasound estimation of gestational age
1166. Proposed role of copper-molybdenum interaction in iron-deficiency and iron-storage diseases
1167. Catabolic pathways for high-dosed L(-) or D(+)-carnitine in germ-free rats?
1168. Folic acid
1169. Iodine in human milk: Perspectives for infant health
1170. Effects of vitamin D and phosphorus supplementation on calcium retention in preterm infants fed banked human milk
1171. Increased prevalence of developmental dental defects in low birth-weight, prematurely born children: A controlled study
1172. Effect of manganese on neonatal rat: Manganese concentration and enzymatic alterations in brain
1173. Extracellular fluid volume changes in very low birth weight infants during first 2 postnatal months
1174. Postnatal weight changes in low birth weight infants
1175. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants
1176. Parenteral nutrition in the management of sick low birthweight infants
1177. Trace elements in the fetus and young infant. II. Copper, manganese, selenium, and chromium
1178. Iron absorption by the premature infant. The effect of transfusion and iron supplements on the serum ferritin levels
1179. Geographic distribution of selenium in human milk
1180. Vitamin A
1181. Tissue carnitine reserves of newborn infants
1182. Carnitine status at birth of newborn infants of varying gestation
1183. Plasma vitamin A and retinol-binding protein in premature and term neonates
1184. Nutritional balance studies in very-low-birth-weight infants: Role of whey formula
1185. Nutritional balance studies in very-low-birth-weight infants: Enhanced nutrient retention rates by an experimental formula
1186. Magnesium
1187. Synergistic effect of a choline-devoid diet and phenobarbital in promoting the emergence of foci of γ-glutamyltranspeptidase-positive hepatocytes in the liver of carcinogen-treated rats
1188. 12 deficiency in pregnancy and in the neonatal period
1189. Folic acid deficiency and prematurity
1190. Randomised controlled trial of L-carnitine as a nutritional supplement in preterm infants
1191. In vivo measurements of glucose absorption in preterm infants
1192. Absorption of lactose, glucose polymers, or combination in premature infants
1193. Early feeding, feeding tolerance, and lactase activity in preterm infants
1194. Zinc absorption and intestinal losses of endogenous zinc in young Chinese women with marginal zinc intakes
1195. Molybdenum balance studies in premature male infants
1196. Trace element excess in PKU diets?
1197. Molybdenum supply of very low-birth-weight premature infants during the first months of life
1198. Iron requirement in low birthweight infants
1199. Prevention of anemia and iron deficiency in very low-birth-weight infants
1200. High plasma vitamin C concentrations at birth associated with low antioxidant status and poor outcome in premature infants
1201. Antioxidant activity, packed cell transfusions, and outcome in premature infants
1202. Energy balance of the newborn
1203. Behavioral and dermatologic changes and low serum zinc and copper concentrations in two premature infants after parenteral alimentation
1204. Dietary-dependent carnitine deficiency as a cause of nonketotic hypoglycemia in an infant
1205. Selenium and glutathione peroxidase levels in premature infants in a low selenium community (Christchurch, New Zealand)
1206. Selenium status of preterm infants fed human milk, preterm formula, or selenium-supplemented preterm formula
1207. Folate supplementation during lactation: Maternal folate status, human milk folate content, and their relationship to infant folate status
1208. Folate intake and blood concentrations of term infants
1209. Selenium intakes and status of human milk and formula fed infants
1210. Oxidant stress responses in premature infants during exposure to hyperoxia
1211. Vitamin A transport in human vitamin A toxicity
1212. Plasma carnitine alterations in premature infants receiving various nutritional regimes
1213. The protein and amino acid requirements of the premature infant
1214. The protein requirement of the premature infant. I. The effect of protein intake on the retention of nitrogen
1215. Protein requirement of the premature infant. II. Influence of protein intake on free amino acid content of plasma and red blood cells
1216. The minimum riboflavin requirement of the infant
1217. Argininemia
1218. Evoked potential and preferential looking estimates of visual acuity in pediatric patients
1219. Studies on the bioavailability of zinc in humans: Effects of heme and nonheme iron on the absorption of zinc
1220. Conceptual issues concerning the assessment of nutrient bioavailability
1221. Fluoride in human milk
1222. Human intrauterine growth and nutrient accretion
1223. Glycogen regulation in isolated perfused near term monkey liver
1224. Regulation of rat liver glycogen synthesis and activities of glycogen cycle enzymes by glucose and galactose
1225. Vitamin and mineral supplementation
1226. Low serum calcium and high parathyroid hormone levels in neonates fed "humanized" cow's milk-based formula
1227. Whole blood manganese levels in pregnancy and the neonate
1228. The ontogeny of liver copper metabolism in the guinea pig: Clues to the etiology of Wilson's disease
1229. Routine L-ascorbic acid supplementation does not alter iron, copper, and zinc balance in low-birthweight infants fed a cows'-milk formula
1230. Manganese intake and serum manganese concentration of human milk-fed and formula-fed infants
1231. Effect of carbohydrates on calcium absorption in premature infants
1232. Synthesis of cysteine from methionine in normal adult subjects: Effect of route of alimentation
1233. Osteopenia of prematurity: The cause and possible treatment
1234. Riboflavin deficiency in infants and children with heart disease
1235. Effect of malnutrition on activity of two enzymes concerned with amino acid metabolism in human liver
1236. Folic acid supplementation in low birth weight infants
1237. Quantitative selenium metabolism in normal New Zealand women
1238. Prostanoid formation during feeding of a preterm formula with longchain polyunsaturated fatty acids in healthy preterm infants during the first weeks of life
1239. Chapter 34.Chromium
1240. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and ω-3 fatty acids in muscle phospholipid
1241. Lipid peroxidation and expression of copper-zinc and manganese superoxide dismutase in lungs of premature infants with hyaline membrane disease and bronchopulmonary dysplasia
1242. Transfusion therapy in neonates
1243. On the safety of Mortierella alpina for the production of food ingredients, such as arachidonic acid
1244. Diagnosis and management of folate deficiency in low birthweight infants
1245. Copper deficiency in infants
1246. Taurine in development
1247. Taurine in pediatric nutrition
1248. The biology of taurine in nutrition and development
1249. Retinal degeneration in primates raised on a synthetic human infant formula
1250. Bioequivalence of dietary α-linolenic and docosahexaenoic acids as sources of docosahexaenoate accretion in brain and associated organs of neonatal baboons
1251. Repeated fluorodeoxyglucose positron emission tomography of the brain in infants with suspected hypoxic-ischaemic brain injury
1252. Effects of high carnitine supplementation on substrate utilization in low-birth-weight infants receiving total parenteral nutrition
1253. Quantitation of oxidation of medium-chain triglycerides in preterm infants
1254. Comparison of two preterm formulas with or without addition of medium-chain triglycerides (MCTs). I: Effects on nitrogen and fat balance and body composition changes
1255. Iron, plasma antioxidants, and the 'oxygen radical disease of prematurity'
1256. Serum antioxidant activity in neonates
1257. Renal response to vasopressin in premature infants: What is new?
1258. Relationship between maturity, electrolyte balance and the function of the renin-angiotensin-aldosterone system in newborn infants
1259. Influence of NaCI supplementation on vasopressin secretion and water excretion in premature infants
1260. Postnatal development of renal sodium handling in premature infants
1261. A histological study of the chronology of initial mineralization in the human deciduous dentition
1262. Glucose production rate in extremely immature neonates (< 28 weeks) studied by use of deuterated glucose
1263. The importance of menaquinones in human nutrition
1264. Vitamin K
1265. Copper deficiency in the preterm infant of very low birthweight. Four cases and a reference range for plasma copper
1266. A comparative study of varying protein intake in low birthweight infant feeding
1267. Protein and amino acid composition of bovine milk
1268. Fecal short-chain fatty acids predict digestive disorders in premature infants
1269. Ion chromatographic determination of inositol in infant formulae and clinical products for enteral feeding
1270. On-off study of manganese administration to adult patients undergoing home parenteral nutrition: New indices of in vivo manganese level
1271. Water balance, electrolytes and acid-balance in extremely premature infants
1272. Improved medium for selective isolation and enumeration of bifidobacterium
1273. Hyperammonemia in neonates receiving intravenous nutrition
1274. Role of selenium in the nutrition of the chick
1275. Interrelation of intestinal transport system for manganese and iron
1276. Nucleotides in human milk: Sources and metabolism by the newborn infant
1277. Ability to provide adequate nutrition to very low birth weight (VLBW) infants in a neonatal intensive care unit
1278. Plasma amino acids in preterm infants after a feed of human milk or formula
1279. Plasma amino acids in term neonates after a feed of human milk or formula. II. Characteristic changes in individual amino acids
1280. The vitamin C content of the liver of newborn infants
1281. Vitamin E
1282. Taurine and osmoregulation: Taurine is a cerebral osmoprotective molecule in chronic hypernatremic dehydration
1283. Taurine and osmoregulation. II. Administration of taurine analogues affords cerebral osmoprotection during chronic hypernatremic dehydration
1284. Sialic acid content of infant saliva: Comparison of breast fed with formula fed infants
1285. Determining the vitamin and mineral requirements in preterm infants: An introduction
1286. Glutathione peroxidase and selenium levels in the preterm infant
1287. Transient hyperammonemia of the newborn: A vascular complication of prematurity
1288. A comparative study of a premature infant formula and preterm breast milk for low birthweight infants
1289. Human whole-body copper metabolism
1290. Dietary molybdenum
1291. Molybdenum absorption, excretion, and retention studied with stable isotopes in young men at five intakes of dietary molybdenum
1292. Molybdenum absorption, excretion, and retention studied with stable isotopes in young men during depletion and repletion
1293. Molybdenum absorption and utilization in humans from soy and kale intrinsically labeled with stable isotopes of molybdenum
1294. Zinc and copper balances in preterm infants
1295. Selenate fortification of infant formulas improves the selenium status of preterm infants
1296. Randomized trial of taurine supplementation for infants <1,300-gram birth weight: Effect on auditory brainstem-evoked responses
1297. Growth, metabolic response, and development in very-low-birth-weight infants fed banked human milk or enriched formula. I. Neonatal findings
1298. More on taurine
1299. Vitamin A supplementation for extremely-low-birthweight infants
1300. Table 22. Infant mortality rates according to birthweight: United States, selected birth cohorts 1983-97
1301. Visual and brain function measurements in studies of n-3 fatty acid requirements of infants
1302. Conditionally essential nutrients: Cysteine, taurine, tyrosine, arginine, glutamine, choline, inositol, and nucleotides
1303. Safety and efficacy of omega-3 fatty acids in the nutrition of very low birth weight infants: Soy oil and marine oil supplementation of formula
1304. Long chain polyunsaturated fatty acid formation in neonates: Effect of gestational age and intrauterine growth
1305. Essentiality of copper in humans
1306. Role of nucleotides in intestinal development and repair: Implications for infant nutrition
1307. Effect of dietary omega-3 fatty acids on retinal function of very-low-birthweight neonates
1308. 6, vitamin C and folacin levels in milk from mothers of term and preterm infants during the neonatal period
1309. Fetal growth patterns in a population of Danish newborn infants
1310. Altitude, low birth weight, and infant mortality in Colorado
1311. The respiratory distress syndrome of prematurity. I. Changes in potassium in the serum and the electrocardiogram and effects of therapy
1312. Intrauterine growth of live-born Caucasian infants at sea level: Standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation
1313. Influence of ascorbic acid supplementation on copper metabolism in rats
1314. Composition of postnatal weight loss and subsequent weight gain in small for dates newborn infants
1315. Glucose kinetics and glucoregulatory hormone levels in ventilated preterm infants on the first day of life
1316. Short-term growth and substrate use in very-low-birth-weight infants fed formulas with different energy contents
1317. Selenium deficiency in total parenteral nutrition
1318. Curly tail: A 50-year history of the mouse spina bifida model
1319. Vitamin E status in preterm infants: Assessment by plasma and erythrocyte vitamin E-lipid ratios and hemolysis tests
1320. A multicenter long-term safety and efficacy trial of preterm formula supplemented with long-chain polyunsaturated fatty acids
1321. Evaluation of a long-chain polyunsaturated fatty acid supplemented formula on growth, tolerance, and plasma lipids in preterm infants up to 48 weeks postconceptional age
1322. Folic acid status in premature infants
1323. Longitudinal changes in the mineral content of human milk
1324. Analytical issues in nutritional chromium research
1325. Derivation of the reference dose for manganese
1326. Calcium, magnesium and phosphorus in the nutrition of the newborn
1327. Brush-border inositol transport by intestines of carnivorous and herbivorous teleosts
1328. The biochemistry of chromium
1329. Visual function in patients undergoing long-term total parenteral nutrition
1330. L-cysteine and glutathione metabolism are impaired in premature infants due to cystathionase deficiency
1331. Taurine concentrations in plasma, blood cells, and urine of children undergoing longterm total parenteral nutrition
1332. Vitamin E and C levels in infants during the first year of life
1333. Trace element supply in young, healthy infants as related to trace element content of diet
1334. Transferrin bei Fröhgeborenen
1335. Vitamin C
1336. The concentrations of copper and zinc in human milk: A longitudinal study
1337. The effects of the dietary intakes of copper, iron, manganese, and zinc on the trace element content of human milk
1338. Chloride deficiency syndrome in older exclusively breast-fed infants
1339. Effects of different formula feeds on the developmental pattern of urinary bile acid excretion in infants
1340. Iron deficiency anemia: Adverse effects on infant psychomotor development
1341. Long-chain polyunsaturated fatty acid levels in formulae influence deposition of docosahexaenoic acid and arachidonic acid in brain and red blood cells of artificially reared neonatal rats
1342. Comparison of serum carnitine and ketone body concentrations in breast- and in formula-fed newborn infants
1343. The present place of routine ultrasound screening
1344. Effect of taurine on synthesis of neutral and acidic sterols and fat absorption in preterm and full-term infants
1345. Zinc absorption, distribution, excretion, and retention by healthy preterm infants
1346. Basic concepts in the determination of nutritional requirements of normal infants
1347. Bile salt metabolism in the human premature infant: Preliminary observations of pool size and synthesis rate following prenatal administration of dexamethasone and phenobarbital
1348. Developmental aspects of carbohydrate malabsorption in the premature infant
1349. Premature infants fed mothers' milk to 6 months corrected age demonstrate adequate growth and zinc status in the first year
1350. Moderate nutrient supplementation of mother's milk for preterm infants supports adequate bone mass and short-term growth: A randomized, controlled trial
1351. Influence of dietary choline availability and neuronal demand on acetylcholine synthesis by rat brain
1352. Choline utilization by central cholinergic neurons
1353. True absorption and endogenous fecal excretion of manganese in relation to its dietary supply in growing rats
1354. A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until nine months
1355. Chapter 18. Feeding methodologies
1356. 6 intake on the content of the vitamin in human milk
1357. Visual membranes: Specificity of fatty acid precursors for the electrical response to illumination
1358. Fluoride
1359. Energy balance and nitrogen balance in growing low birthweight infants fed human milk or formula
1360. Evaluation of single cell sources of docosahexaenoic acid and arachidonic acid: A 4-week oral safety study in rats
1361. Trace elements in human development
1362. Accumulation of Cu, Zn, Mn, Cr and Co in the human liver before birth
1363. Trace elements in foetal and early postnatal development
1364. Chemical composition of the body
1365. Fetal growth and body composition
1366. Chemical development in utero
1367. 58Fe in premature infants treated with erythropoietin
1368. Copper deficiency in humans
1369. Role of dietary iron and fat on vitamin E deficiency anemia of infancy
1370. Selenium and glutathione peroxidase in mature human milk
1371. Plasma manganese, selenium and glutathione peroxidase levels in the mother and newborn infant
1372. Effect of blood transfusion on plasma selenium, glutathione peroxidase and manganese levels in very low birth weight infants
1373. Plasma manganese levels in the very low birth weight infant are high in early life
1374. Plasma carnitine deficiency. Clinical observations in 51 pediatric patients
1375. Effect of lactose on mineral absorption in preterm infants
1376. Molecular basis of pulmonary oxygen toxicity
1377. Erythrocyte and plasma cholesterol ester long-chain polyunsaturated fatty acids of low-birth-weight babies fed preterm formula with and without ribonucleotides: Comparison with human milk
1378. The partial replacement of dietary methionine by cystine for purposes of growth
1379. Fetal growth at sea level
1380. Assessment of marginal zinc status in humans
1381. Vitamin A status of preterm infants: The influence of feeding and vitamin supplements
1382. The metabolism of tyrosine and phenylalanine in premature infants: The effect of large doses
1383. Iodine
1384. Molybdenum
1385. Selenium
1386. The effects of the introduction of a high nutrient transitional formula on growth and development of very low birth weight (VLBW) infants to 18 months corrected age (CA)
1387. +/glucose cotransporter
1388. New postnatal growth grids for very low birth weight infants
1389. Human selenium requirements in China
1390. Studies of human maximal and minimal safe intake and requirement of selenium
1391. Does iron supplementation compromise zinc nutrition in healthy infants?
1392. Selenium content of commercial formula diets
1393. Influence of dietary taurine on vitamin D absorption
1394. Renal handling of carnitine in ill preterm and term neonates
1395. Plasma L-arginine concentration, oxygenation index, and systemic blood pressure in premature infants
1396. Plasma L-arginine concentrations in premature infants with necrotizing enterocolitis
1397. Dietary choline: Biochemistry, physiology, and pharmacology
1398. Choline
1399. Choline, phosphatidylcholine and sphingomyelin in human and bovine milk and infant formulas
1400. Taurine depletion in very low birth weight infants receiving prolonged total parenteral nutrition: Role of renal immaturity
1401. Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans
1402. Water and electrolytes
1403. Infants of low birth weight: Special needs and problems
1404. Protein requirements of preterm infants
1405. Nutritional factors influencing calcium and phosphorus absorption in infants
1406. Protein in premature feeding
1407. Nutritional requirements of the premature infant
1408. Lactose enhances mineral absorption in infancy
1409. Potential renal solute load of infant formulas
1410. Body composition of the reference fetus
1411. Renal solute load and diet in growing premature infants
1412. 70Zn as extrinsic tag
1413. Acrodermatitis in breast-fed premature infants: Evidence for a defect of mammary zinc secretion
1414. Lactose does not enhance calcium bioavailability in lactose-tolerant, healthy adults
1415. The development of cystathionase activity during the first year of life
1416. Cysteine supplementation to cysteine-free intravenous feeding regimens in newborn infants
1417. Manganese intakes in intravenously fed infants: Dosages and toxicity studies
1418. Response letter
1419. Trace elements in nutrition for premature infants
1420. Intravenous nitrogen and energy intakes required to duplicate in utero nitrogen accretion in prematurely born human infants
1421. Meeting zinc and copper intake requirements in the parenterally fed preterm and full-term infant
1422. Hepatic metallothionein as a source of zinc and cysteine during the first year of life
1423. 58Fe) in very low birthweight premature infants
1424. Megaloblastic anemia in infancy
1425. Megaloblastic anemia of infancy